TWI283267B - Bactericidal antifouling detergent for hard surface - Google Patents

Bactericidal antifouling detergent for hard surface Download PDF

Info

Publication number
TWI283267B
TWI283267B TW90120399A TW90120399A TWI283267B TW I283267 B TWI283267 B TW I283267B TW 90120399 A TW90120399 A TW 90120399A TW 90120399 A TW90120399 A TW 90120399A TW I283267 B TWI283267 B TW I283267B
Authority
TW
Taiwan
Prior art keywords
group
acid
carbon number
monomer unit
antifouling
Prior art date
Application number
TW90120399A
Other languages
Chinese (zh)
Inventor
Shin Aihara
Noriyuki Morii
Kazunori Tsukuda
Hiroyuki Yamada
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Application granted granted Critical
Publication of TWI283267B publication Critical patent/TWI283267B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/38Cationic compounds
    • C11D1/62Quaternary ammonium compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/37Polymers
    • C11D3/3746Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C11D3/3769(Co)polymerised monomers containing nitrogen, e.g. carbonamides, nitriles or amines

Abstract

A bactericidal antifouling detergent for hard surfaces which comprises (a) a polymer which has a weight average molecular weight of 1,000 to 6,000,000 and in which monomer units having at least one group selected from quaternary ammonium groups and tertiary amino groups account for 10 to 100 mol% of all the monomer units, (b) a bactericidal compound having a molecular weight lower than 1,000 and having a quaternary ammonium group, and (c) a surfactant, and in which when the detergent comprises an anionic surfactant (cA), the ratioof (cA) to (b) by weight (i.e., cA/b) does not exceed 1.0. The bactericidal antifouling detergent sterilizes hard surfaces and shows antifouling properties, i.e., prevents fouling substances from adhering thereto and enables fouling substances adherent thereto to be easily removed. When used in a whole house, especially when applied to the walls and floors of the kitchen, bathroom, toilet, washstand, etc. and to instruments and apparatuses placed therein, the detergent enables sterilization, prevention of fouling substance adhesion, and easy cleaning.

Description

五、發明説明(彳) 發明之所屬技術領域 本發明係關於一種硬質表面用之清潔劑組合物,其可成 爲硬質表面之殺菌、及防污性、亦即污垢之附著防止、以 及容易除去所附著之污垢,當使用於一般居家、尤其廚 房、浴室、廁所、洗面台等、牆或地板、器具、機器等 時,可殺菌以及污垢之附著防止及易洗淨。 ' 習知技術 在生活上於各式各樣場所均會造成污垢。爲除去此等污 垢,遂開發各種清潔劑,爲強化其洗淨力之研究乃隨之而 起。藉由此等努力,提案出許多用以除去頑固污垢的方 法。 又’如此地開發出除污性優之清潔劑,另外,有關使污 垢很難附著之技術及實施處理而易除去附著之污垢的技術 (以後稱爲防污性)亦常被研究,發現應用來作爲清潔劑之 技術。例如在特開平2_ 145697號公報中,調配特定構造之 磺甜菜鹼型兩性界面活性劑的水洗廁所用清潔劑已被記 載;在特開平3 -35097號公報中,含有磺琥珀酸二酯之軟 便附著防止性優且洗淨效果高之水性廁所用清潔劑已有記 載;在特開平1 〇 - 1697號公報中,以特定比率調配特定之 界面活性劑與水溶性溶劑的清潔劑已被記載。尤其,於特 開平9- 169995號公報中,水對處理後之硬質表面的接觸角 爲3 0度以下之清潔劑顯示優異的防污性,具體上,防污基 劑可舉例:陰離子界面活性劑與分子中含有4級銨基之界 面活性劑或水溶性聚合物的組合。5. TECHNOLOGICAL FIELD OF THE INVENTION The present invention relates to a detergent composition for a hard surface which can be used for sterilization of a hard surface, and antifouling property, that is, adhesion prevention of dirt, and easy removal. Adhesive dirt can be used for sterilization and dirt adhesion and easy to clean when used in general homes, especially kitchens, bathrooms, toilets, washstands, walls, floors, appliances, machines, etc. 'Knowledge technology can cause dirt in all kinds of places in life. In order to remove such dirt, various cleaning agents have been developed, and research to enhance the detergency has followed. By doing so, many proposals have been made to remove stubborn dirt. In addition, a technique for decontaminating excellent cleaning agents has been developed, and a technique for making it difficult to adhere to dirt and a technique for easily removing the adhered dirt (hereinafter referred to as antifouling property) have been frequently studied and found to be applied. Come as a cleaning agent technology. For example, Japanese Laid-Open Patent Publication No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. A water-based toilet cleaner having an excellent adhesion prevention property and a high cleaning effect has been described. In Japanese Laid-Open Patent Publication No. Hei-1697, a detergent having a specific ratio of a specific surfactant and a water-soluble solvent has been described. In particular, in the Japanese Patent Publication No. Hei 9-169995, the cleaning agent having a water contact angle of 30° or less on the hard surface after the treatment exhibits excellent antifouling properties. Specifically, the antifouling agent can be exemplified by an anionic interface activity. A combination of a surfactant and a surfactant having a level 4 ammonium group or a water-soluble polymer in the molecule.

本紙張尺瓦^中@ S家_CN石鐵格(露297公爱) 1283267The paper ruler ^ @@家_石石格格(露297公爱) 1283267

如以上般,自以往有關防污性之技術常被研究。然而, 習知技術係以抑制水垢或便等附著所產生的(亏垢爲主轴 有關微生物或黴菌造成的黑點之污垢乃不夠充分。加上 最近隨著生活環境之改善,眼睛所看到之污垢,在衛生方 面之問題掛念的人增加,對於殺菌之要求亦高張。 有關如此之设囷的想法乃提出殺菌劑之配方。然而,轉 一般使用於家庭之殺菌劑調配於前述殺菌劑時,防污性與 殺菌性之兩者效果會互剋,要達成可滿足之殺菌性及防污 性乃極爲困難。 本發明之課題係提供一種可使用家庭、在廁所、浴室、 場房周遭等之硬質表面的洗淨中,不只具優異之洗淨力而 亦可滿足殺菌性及防污性兩者之水準巧清潔劑。 本發明之揭示 本發明係關於一種硬質表面用殺菌防污清潔劑,其係包 括(a)重量平均分子量爲,包含單體(具有 至V個選自4級按基及3級胺基之基)單元其比率(相對於 全單體單元爲10〜100莫耳%、(b)分子量爲1〇〇〇以下,且 具有4級銨基之殺菌性化合物、及(c )界面活性劑;當含有 (CA)陰離子界面活性劑作爲界面活性劑時,(cA)/(b)^重 量比率不超過1.0。 (a)成分:E含有〇·〇ι〜3〇重量%、(b)成分宜含有 0.001〜3 0重量%、及(c)成分含有〇 〇1〜5 〇重量%。 本發明係提供一種使上述組合物適用於硬質表面以清潔 劑硬質表面並殺菌,繼而可防止防垢附著於硬質表面之方 本紙張尺度適用中國國家標準(CNS) -5- 1283267 A7 B7 五、發明説明(3 ) 法,及,一種使上述組合物清潔硬質表面,並可防止污垢 附著於硬質表面之用途。 發明之詳細説明 本發明之(a)成分係一種含有一具4級銨基及/或3級胺基 之單體單元(以下稱爲單體單元)1〇〜100莫耳%的聚合物。 單體單元A可使含有4級銨基(亦可爲複數)之單體(以下 稱爲單體A)聚合或使含有3級胺基(亦可爲複數)之單體(以 下稱爲單體A’)所得到之單體單元,亦可爲3級胺基經4級 化而成爲4級銨化者。 具有4級銨基之單體A的較佳例,亦即,源自單體單元a 之例,可舉例下述式(4)的化合物。As above, techniques related to antifouling have been studied from the past. However, conventional techniques are produced by inhibiting the adhesion of scales or the like (the scale is a scar of the black spots caused by microorganisms or molds on the main axis. In addition, recently, as the living environment improves, the eyes see it. Dirt, the number of people who are concerned about hygiene problems is increasing, and the requirements for sterilization are also high. The idea of such a design is to propose a formula of a fungicide. However, when it is used in a household fungicide, the above-mentioned fungicide is used. Both the antifouling property and the bactericidal effect are mutually versatile, and it is extremely difficult to achieve satisfactory bactericidal and antifouling properties. The object of the present invention is to provide a home, a toilet, a bathroom, a room, etc. In the cleaning of the hard surface, not only the excellent detergency but also the sterilizing and antifouling properties of the cleaning agent can be satisfied. The present invention relates to a sterilizing and antifouling cleaning agent for hard surfaces, It comprises (a) a weight average molecular weight of a monomer (having up to V units selected from the group consisting of a 4-stage group and a 3-stage amine group) in a ratio (relative to the all monomer unit) 10 to 100 mol %, (b) a bactericidal compound having a molecular weight of 1 Å or less, having a 4-stage ammonium group, and (c) a surfactant; when a (CA) anionic surfactant is contained as a surfactant When the ratio of (cA)/(b)^ is not more than 1.0. (a) Component: E contains 〇·〇ι~3〇% by weight, (b) component preferably contains 0.001 to 30% by weight, and (c) The composition contains 〇〇1~5 〇% by weight. The present invention provides a method for applying the above composition to a hard surface to clean the surface of the cleaning agent and sterilizing, thereby preventing the scale from adhering to the hard surface. (CNS) -5- 1283267 A7 B7 V. Inventive Note (3), and a use of the above composition for cleaning a hard surface and preventing dirt from adhering to a hard surface. DETAILED DESCRIPTION OF THE INVENTION (a) The component is a polymer having a 4-stage ammonium group and/or a 3-stage amine group (hereinafter referred to as a monomer unit) in an amount of from 1 to 100 mol%. The monomer unit A may contain a 4-grade ammonium. a monomer (also referred to as a plurality of monomers) (hereinafter referred to as monomer A) is polymerized or contained a monomer unit obtained by a monomer having a 3-stage amine group (which may also be a plural number) (hereinafter referred to as a monomer A'), or a level 3 amine group may be classified into a 4-stage ammonium group by 4 stages. A preferred example of the monomer A of the fourth-order ammonium group, that is, an example derived from the monomer unit a, may be exemplified by the compound of the following formula (4).

Rl2Rl3c = c(Fi4 )- /15 R16 R17 γ- (4) 式中’ R12、R13、R14分別爲氫原子、幾基或破數1〜3 的烷基。X乃選自碳數1〜12之缔烴基、-COOR18-、 -CONHR18-、-OCOR18-、-R19-OCO-R18·之基。此處, R18、R19分別爲碳數1〜5的晞烴基。R15爲碳數1〜3之烷 基或經燒基或R12R13C = C(R14)-X-。R16爲竣數1〜3之貌 基、羥烷基、苯甲基,R 1 7爲羥基、羧‘基、續酸或硫酸酯 基所取代之碳數1〜10的烷基或苯甲基,R1 7爲烷基、羥烷 基或苯甲基時,Y·爲陰離子。 -6- 本紙張尺度適用中國國家標準(CNS) A4規格(21〇χ297公釐) 1283267 A7 B7Rl2Rl3c = c(Fi4)- /15 R16 R17 γ- (4) wherein R12, R13 and R14 are each a hydrogen atom, a few groups or an alkyl group having a number of 1 to 3. X is selected from the group consisting of a hydrocarbon group having 1 to 12 carbon atoms, -COOR18-, -CONHR18-, -OCOR18-, -R19-OCO-R18. Here, R18 and R19 are each an anthracene hydrocarbon group having 1 to 5 carbon atoms. R15 is an alkyl group having 1 to 3 carbon atoms or a burnt group or R12R13C = C(R14)-X-. R16 is a vinyl group having 1 to 3 moles, a hydroxyalkyl group or a benzyl group, and R 1 7 is a hydroxyl group, a carboxy group, a carboxylic acid group or a sulfate group substituted with an alkyl group having 1 to 10 carbon atoms or a benzyl group. When R1 7 is an alkyl group, a hydroxyalkyl group or a benzyl group, Y· is an anion. -6- This paper scale applies to Chinese National Standard (CNS) A4 specification (21〇χ297 mm) 1283267 A7 B7

又,R17含有羥基、磺酸基、硫酸酯基時,γ·不存在, 而R17中之此等基爲陰離子。γ-之陰離子可舉例:鹵素離 子、硫酸離子、碳數1〜3之烷基硫酸酯離子、碳數1〜3之 烷基所取代之芳香族磺酸離子、羥基離子。 此等之中,宜爲丙烯醯基(或甲基丙晞醯基)胺基烷基(碳 數1 5)-Ν,Ν,Ν-二燒基(碳數1〜3 ) 4級按鹽、丙缔酸(或甲 基丙晞醯)氧烷基(碳數1〜5)-Ν,Ν,Ν -三烷基(碳數1〜3)4 級銨鹽、Ν-[ω-烷晞基(碳數3〜10)卜Ν,Ν,Ν-三烷基(碳數 1〜3)4級銨鹽、Ν,Ν-二(ω -烷烯基(碳數3〜1 0)]-Ν,Ν-二 烷基(碳數1〜3)4級銨鹽,尤以二烷基二曱基銨鹽爲佳。 3級胺基之單體Α,的較佳例亦即源自單體單元Α,之化合 物可舉例下述式(5)之化合物。 R12 13 /R15R C=C(R14)—X—Ν (5)Further, when R17 contains a hydroxyl group, a sulfonic acid group or a sulfate group, γ· does not exist, and these groups in R17 are anions. The anion of γ- can be exemplified by a halogen ion, a sulfate ion, an alkyl sulfate ion having 1 to 3 carbon atoms, an aromatic sulfonate ion substituted with an alkyl group having 1 to 3 carbon atoms, and a hydroxyl ion. Among these, it is preferably a propylene fluorenyl (or methacrylamido)aminoalkyl group (carbon number 15)-fluorene, fluorene, fluorene-dialkyl (carbon number 1 to 3) , propionic acid (or methyl propyl hydrazine) oxyalkyl (carbon number 1 to 5) - hydrazine, hydrazine, hydrazine - trialkyl (carbon number 1 to 3) 4th ammonium salt, Ν-[ω-alkane Sulfhydryl (carbon number 3 to 10) diterpenoid, anthracene, fluorene-trialkyl (carbon number 1 to 3) 4-grade ammonium salt, hydrazine, hydrazine-bis(ω-alkenyl group (carbon number 3 to 1 0) ]-Ν, Ν-dialkyl (carbon number 1 to 3) 4-grade ammonium salt, especially dialkyldicylidene ammonium salt. Preferred examples of the tertiary amine-based monomer oxime From the monomer unit, the compound of the following formula (5) can be exemplified. R12 13 /R15R C=C(R14)—X—Ν (5)

式中,^^、^^、^^,^^及尺以乃與前述記載相同。 此等之中,宜爲Ν,Ν·二烷基(碳數1〜3)胺基烷基(碳數 1〜5)丙晞酸酯(或甲基丙晞酸酯)、ν,ν-二烷基(碳數^3) 胺基燒基(碳數1〜5)丙晞醯胺、ν,Ν -二(ω -烷烯基(碳數 3〜10))-Ν -甲胺,尤宜爲二烯丙基甲胺。 使單體A ’ 4級化時,4級化劑宜使用氣化曱淀、溴化甲 燒、苯甲基氣、二甲基硫酸、二乙基硫酸、單氣醋酸或其In the formula, ^^, ^^, ^^, ^^, and ruler are the same as described above. Among these, it is preferably hydrazine, hydrazine, dialkyl (carbon number 1 to 3) aminoalkyl (carbon number 1 to 5) propionate (or methyl propionate), ν, ν- Dialkyl (carbon number: 3) amino group (carbon number: 1 to 5) acrylamide, ν, Ν-bis(ω-alkenyl (carbon number: 3 to 10))-fluorene-methylamine, Particularly preferred is diallylmethylamine. When the monomer A' is 4-staged, it is preferred to use a gasification lake, a brominated methane, a benzyl gas, a dimethyl sulfate, a diethyl sulfate, a mono-acetic acid or the like.

1283267 A7 _____B7 _ 五、發明説明(5 ) ~ ----- 鹽、氣磺酸或其鹽、3-氣_2_羥基丙磺酸或其鹽、環氧乙 烷、環氧丙烷、縮水甘油基醚而進行。又,使用環氧乙 烷、環氧丙烷、縮水甘油基醚時,宜預先以硫酸、鹽酸、 碳數1〜12之羧酸、晞丙基磺酸等中和單體單元後使之反 應。 本發明之(a)成分係不只由單體單元A(亦可爲複數種)所 構成之聚合物,而亦可由單體單元A(亦可爲複數種)與其 他之單體單元(以下,稱爲單體單元…所構成的聚合物。、 (使用單體A,時亦可具有胺型之單體單元)此時,單體單元 A與單體單元B(亦可爲複數種)之排列樣式,係亦可爲嵌 段、交互、周期、統計(包含.隨機)、接枝型之任一種。 由單體單元A與單體單元B所構成之聚合物例如可由各別 之前驅體單體共聚合而得到。此時,單體單元B宜選自下 述1單體群(i)〜(v)的單體單元,更宜源自或 1己載之單體單元,尤其從防污效果之點而言最宜源自(丨)、 (ii)或(v)之單體單元。 (i) 含有陰離子基化合物乃選自丙晞酸或其鹽、甲基丙缔酸 或其鹽、馬來酸或其鹽、馬来酸奸、苯乙晞續酸鹽、績基 丙基甲基丙晞酸酯、2 -丙烯醯胺-2 -甲基丙磺酸或其鹽、 嶙酸單-ω_甲基丙缔酿氧淀基(後數ι〜12)。 (ii) 含有酿胺基之化合物,乃選自丙晞基(或曱基丙晞)酿 胺、N,N-二甲基胺基丙基丙晞酸(或曱墓丙烯酸)醯胺、 N,N -一甲基丙晞基(或甲基丙晞i)酿胺、N -乙晞基·2 -己 内醯胺、Ν _乙烯基-2 -峨咯_。 -8- 1283267 A7 B7 五、發明説明(6 ) (iii) 含有酯基化合物乃選自丙烯酸(或甲基丙烯酸)烷基(碳 數1〜5)、丙烯酸(或甲基丙婦酸)2-羥乙基、丙烯酸(或甲 基丙烯酸)-Ν,Ν-二甲基胺基烷基(碳數1〜5)、乙酸乙晞 酯0 (iv) 化合物乃選自乙晞、丙烯、Ν-丁烯、異丁烯、Ν -戊 稀、異戊間二晞、2 -甲基-1-丁歸·、N -己蹄、2 -甲基-1-戊 烯、3 -甲基-1-戊烯、4·甲基-1-戊烯、2 -乙基-1-丁烯、 苯乙缔、乙烯基甲苯、α -甲基苯乙晞、烯丙基胺、N,N-二烯丙基胺、N,N -二烯丙基-N-烷基(碳數1〜5)胺、環氧 乙燒、環乳丙虎、2_乙晞基ϊ?比淀、4_乙晞基π比症。 〇)二氧化硫。 具有單體單元A與單體單元B之聚合_係可以如前述之共 聚合的合成方法外,可於含有單體單元之聚合物使前述(i) 〜(v)的單體尤其宜前述(i)、(ii)的單體進行接枝聚合而得 到’或,於含有前述(i)〜(v)之單體的聚合物使前述通式(4) 的單體接枝聚合而得到,或,於含前述(丨)〜(v)之單體的聚 合物尤宜含有前述(i)、(ii)的單體之聚合物使前述通式(5) 的單體接枝聚合後,再進行4級化。 在本發明之單體單元B最佳者係具有選自致酸基、續故 基中之一個基[但,不具有4級銨基]單體、亦即,源自前述 (i)單體之單體單元(以下稱爲單體單元B,)。 構成本發明之(a)成分的聚合物可以任倚一種聚合法而得 到,但,以自由基聚合法尤佳,可以塊狀、溶液、或乳化 系來實施。自由基聚合係可藉加熱再開始進行,但啓始劑 -9-1283267 A7 _____B7 _ V. Description of invention (5 ) ~ ----- Salt, gas sulfonic acid or its salt, 3-gas 2 - hydroxypropane sulfonic acid or its salt, ethylene oxide, propylene oxide, shrinkage It is carried out with glyceryl ether. Further, when ethylene oxide, propylene oxide or glycidyl ether is used, it is preferred to neutralize the monomer unit with sulfuric acid, hydrochloric acid, a carboxylic acid having a carbon number of 1 to 12, or propyl sulfonic acid, and then react it. The component (a) of the present invention is a polymer composed not only of the monomer unit A (may be a plurality of types) but also a monomer unit A (may also be a plurality of types) and other monomer units (hereinafter, a polymer composed of a monomer unit. (A monomer unit having an amine type may be used when the monomer A is used.) In this case, the monomer unit A and the monomer unit B (may be plural) The arrangement pattern may also be any one of block, interaction, period, statistics (including random), and graft type. The polymer composed of monomer unit A and monomer unit B may be, for example, individual precursors. The monomer unit B is preferably selected from the monomer units (i) to (v) of the following monomer groups, more preferably derived from or one monomer unit, especially The point of the antifouling effect is most preferably derived from the monomer unit of (丨), (ii) or (v). (i) The anionic compound is selected from the group consisting of propionic acid or its salt, methyl propionate or a salt thereof, maleic acid or a salt thereof, maleic acid, phenethyl phthalate, propyl propyl methacrylate, 2-propenylamine-2-methylpropane sulfonic acid or a salt thereof嶙 单 ω ω ω ω 甲基 ( ( ( ( ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii N-Dimethylaminopropylpropionic acid (or acenaphthyl acrylate) decylamine, N,N-monomethylpropenyl (or methacrylic acid), N-ethyl fluorenyl 2 - Caprolactam, Ν _ vinyl-2-pyrrole _. -8- 1283267 A7 B7 V. Description of invention (6) (iii) The ester-containing compound is selected from the group consisting of acrylic acid (or methacrylic acid) alkyl (carbon) Number 1 to 5), acrylic acid (or methyl procyanoate) 2-hydroxyethyl, acrylic acid (or methacrylic acid)-hydrazine, fluorenyl-dimethylaminoalkyl group (carbon number 1 to 5), acetic acid The oxime ester 0 (iv) compound is selected from the group consisting of acetamidine, propylene, oxime-butene, isobutylene, hydrazine-pentane, isoprene, 2-methyl-1-butane, N-Hexole, 2 -Methyl-1-pentene, 3-methyl-1-pentene, 4·methyl-1-pentene, 2-ethyl-1-butene, phenylethylene, vinyltoluene, α-A Acetophenone, allylamine, N,N-diallylamine, N,N-diallyl-N-alkyl (carbon number 1 to 5) amine, epoxy ethene, ring emulsion tiger 2_ B Xi base ϊ? Than the lake, 4_ B Xi base π than the disease. Billion) sulfur dioxide. The polymerization of the monomer unit A and the monomer unit B can be carried out in the same manner as the above-mentioned copolymerization synthesis method, and the monomer of the above (i) to (v) can be particularly preferably used in the polymer containing the monomer unit ( i) or (ii) a monomer obtained by graft polymerization to obtain 'or a polymer obtained by containing the monomer of the above (i) to (v), wherein the monomer of the above formula (4) is graft-polymerized, Or a polymer containing a monomer of the above (丨) to (v), particularly preferably a polymer of the monomer of the above (i), (ii), after graft-polymerizing a monomer of the above formula (5), Then carry out 4 levels. The monomer unit B of the present invention preferably has a monomer selected from the group consisting of an acid group and a remnant group (but not having a grade 4 ammonium group), that is, derived from the aforementioned (i) monomer. The monomer unit (hereinafter referred to as monomer unit B). The polymer constituting the component (a) of the present invention can be obtained by any polymerization method, but it is preferably a radical polymerization method, and it can be carried out in the form of a block, a solution or an emulsion. Free radical polymerization can be started by heating, but the initiator -9-

1283267 A7 B7 五、發明説明(7 亦可使用2,2,-偶氮雙(2_胺基丙烷)二鹽酸鹽、2,2’-偶氮 雙(N,N-二亞甲基異丁基胺)二鹽酸鹽等之偶氮系啓始劑、 過氧化氫及、過氧化二苯甲醯、三級丁基過氧化氫、氫過 氧化枯烯、曱基乙基酮過氧化物、過安息香酸等之有機過 氧化物、過硫酸鈉、過硫酸鉀、過硫酸銨、等之過硫酸 鹽、過氧化氫-Fe3+等還原氧化啓始劑、等既存的自由基 啓始劑,亦可在光增感劑之存在/或非存在下之光照射、或 以輻射線照射啓始聚合。 本發明之(a)成分係可爲單體單元a之單一聚合物以及選 自單體單元A及單體單元B之共聚合物的聚合物複數種混合 物。 在本發明之(a)成分中更佳的構成,係單體單元a與單體 單元B’的合計量相對於全單體單元爲50〜1〇〇莫耳%,最佳 係單體單元A、B,之莫耳比爲單體單元A/[單體單元a+單 體單元Β’] = 0·3〜0.99者,尤其〇.4〜0.99。 本發明之(a)成分係只要不顯著阻礙本發明之硬質表面用 步又菌防污清潔劑的殺菌性、防污性,亦可含有一不本聚人 物A之其他水溶性聚合物。 本發明之⑷成分係重量平均分子量爲1〇〇〇〜6〇〇〇〇〇〇八 爲 10,000〜6,000,000,尤宜爲 1〇〇,_〜6 〇〇〇,_,其且 平均分子量係以乙猜與水之混合溶劑⑽ 開溶劑,以凝膠滲透色層分析而以聚乙二 馬展 來求取β -肖作馬‘準物質 i爲0.01〜3 〇重 (a)成分係於本發明之殺菌防污清潔劑中 -10-1283267 A7 B7 V. Description of the invention (7 can also use 2,2,-azobis(2-aminopropane) dihydrochloride, 2,2'-azobis(N,N-dimethylene) An azo initiator such as butylamine) dihydrochloride, hydrogen peroxide, and benzoic acid peroxide, tertiary butyl hydroperoxide, cumene hydroperoxide, mercaptoethyl ketone peroxidation Organic peroxides such as benzoic acid, sodium persulfate, potassium persulfate, ammonium persulfate, persulfate, hydrogen peroxide-Fe3+ and other reducing oxidation initiators, and other existing free radical initiators The polymerization may also be initiated by light irradiation in the presence or absence of a photosensitizer or by irradiation with radiation. The component (a) of the present invention may be a single polymer of monomer unit a and selected from the group consisting of a plurality of polymers of the copolymer of the bulk unit A and the monomer unit B. A more preferable composition of the component (a) of the present invention is that the total amount of the monomer unit a and the monomer unit B' is relative to the total The monomer unit is 50 to 1 〇〇 mol%, and the optimum monomer units A and B have a molar ratio of monomer unit A/[monomer unit a+ monomer unit Β'] = 0 3 to 0.99, especially 〇.4 to 0.99. The component (a) of the present invention may contain a bactericidal or antifouling property of the hard surface antifouling detergent of the present invention as long as it does not significantly hinder the hard surface of the present invention. The other water-soluble polymer of the present character A. The component (4) of the present invention has a weight average molecular weight of from 1 〇〇〇 to 6 〇〇〇〇〇〇 八 10,000 to 6,000,000, particularly preferably 1 〇〇, _ 〜 6 〇 〇〇, _, and the average molecular weight is the solvent of the mixed solvent of B guess and water (10), and the gel permeation chromatography is used to obtain the β-Xiao Ma’s quasi-substance i as 0.01 ~3 〇 Heavy (a) component is in the sterilizing and antifouling detergent of the present invention -10-

1283267 A7 B7 五、發明説明(8 ) 量%,詳而言之,係以觸發器或噴霧器等之噴霧裝置、 或、塗布之方法來洗淨對象之硬質表面時,(a)成分之濃度 爲0.01〜10重量%,更宜爲0.02〜5重量%,另外,在利用廁 所水槽内之水的洗淨方法中,於水槽内或任意的給水徑路 設置裝置,可將適量的洗淨液投入水槽的水,而利用此廁 所用自動洗淨器時,含有1〜30重量%,更宜爲2〜20重量 %。又,水槽内之(a)成分的濃度宜0.1〜10 ppm。 本發明之(b)成分係分子量爲1,000以下較佳爲具有500以 下之至少一個4級銨基的殺菌性化合物。在本發明所謂之 殺菌性化合物係謂以下述方法所測定的菌落數爲1 0以下的 性質之化合物。 <殺菌性化合物測定方法> 使用大腸菌(Escherichia Coli : IF 03972)與黃色葡萄球菌 (Staphylococcus aureus : IFO12732 )作爲供試菌。IF03972 與IF012732係寄託於日本國大阪府市淀川區十三本町二町 目17番85號在財團法人發酵研究所Institute for Fermentation, Osaka,可分讓。 調製試驗化合物[(b)成分]之1重量%水溶液,於該水溶 液2 ml加入1 08〜1 0 9之細菌浮遊液50 " 1,充分混合後,放 置5分鐘。放置後,採取此混合液0.1 ml而加入0.9 ml之LP 稀釋液中,·充分混合,使前述化合物對菌之影響降低,然 後,將此混合液塗布於SCDLP瓊脂培養液上,大腸菌在37 °C下培養2 4小時,黃色葡萄球諸在3 7 °C下培養4 8小時。 培養後所生育的菌落數計數之。又,殺菌試驗係對於相同 -11 - 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)1283267 A7 B7 V. INSTRUCTIONS (8) Quantities, in detail, when the hard surface of the object is washed by a spray device such as a trigger or a sprayer, or by a coating method, the concentration of the component (a) is 0.01 to 10% by weight, more preferably 0.02 to 5% by weight, and in the washing method using the water in the toilet tank, an appropriate amount of the cleaning liquid can be put into the water tank or any water supply path. The water in the sink is 1 to 30% by weight, more preferably 2 to 20% by weight, when using the automatic washing device for the toilet. Further, the concentration of the component (a) in the water tank is preferably 0.1 to 10 ppm. The component (b) of the present invention is a bactericidal compound having a molecular weight of 1,000 or less, preferably at least one of the quaternary ammonium groups of 500 or less. The bactericidal compound referred to in the present invention is a compound having a property in which the number of colonies measured by the following method is 10 or less. <Method for measuring bactericidal compound> Escherichia Coli (IF 03972) and Staphylococcus aureus (IFO12732) were used as test bacteria. IF03972 and IF012732 are attached to the Institute for Fermentation, Osaka, the No. 85, No.15, Sakamotocho, Yodogawa-cho, Yodogawa-ku, Osaka, Japan. A 1% by weight aqueous solution of the test compound [(b) component] was prepared, and 2 8 to 10 9 of the bacterial floating liquid 50 " 1, was added to 2 ml of the aqueous solution, and the mixture was thoroughly mixed and allowed to stand for 5 minutes. After placing, 0.1 ml of this mixture was added to 0.9 ml of the LP dilution, and the mixture was thoroughly mixed to reduce the effect of the above compound on the bacteria. Then, the mixture was applied to SCDLP agar medium at 37 °. The culture was carried out for 24 hours at C, and the yellow grape balls were cultured at 37 ° C for 48 hours. The number of colonies born after cultivation was counted. In addition, the sterilization test is applicable to the same national standard (CNS) A4 specification (210 X 297 mm) for the same -11 - paper scale.

裝 訂Binding

12832671283267

五、發明説明(9 ) ~ ~ - 7 =物=別同時進行5次(5次X 3)。在此實驗結果中,大 腸囷及更^葡萄球菌兩者之菌落數乃10以下者作爲有殺菌 =。又,前述規定以外之實驗條件的詳細係依據記载於防 囷防黴手册(日本防菌防黴學會編、技報堂出版)的p686之 浮遊試驗法(定量檢測法)。 (b)成分之分子量1,000以下的殺菌性化合物,宜以下述 式(1)〜(3)所示之化合物,其中,尤以水溶性者爲佳。此 處’所謂水溶性乃溶解於2(^c之水η的量爲lg以上。V. Description of the invention (9) ~ ~ - 7 = object = do not perform 5 times at the same time (5 times X 3). In the results of this experiment, the number of colonies of both the large intestine and the more staphylococcus was less than 10 as sterilization. In addition, the details of the experimental conditions other than the above-mentioned regulations are based on the floating test method (quantitative test method) of p686, which is described in the Anti-mite and Anti-Molding Handbook (published by the Japan Society for the Prevention of Bacterial and Mildew, and published by the Technical Bulletin). The bactericidal compound having a molecular weight of 1,000 or less in the component (b) is preferably a compound represented by the following formulas (1) to (3), and particularly preferably water-soluble. Here, the so-called water solubility is dissolved in 2 (the amount of water η is lg or more.

式中’ R1及R6分別爲碳數6〜18,宜爲8〜16之烷基或烷 烯基、更宜爲烷基,R3及R4分別爲碳數1〜3之烷基或羥烷 基。X爲芳香環或選自-COO-、-CONH-、-0C0-、-NHCO-之酯基或醯胺基,R2係X爲酯基或醯胺基時,可爲被羥基 取代之碳數1〜6的烯烴基,X爲芳香環時,爲被羥基取代 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公釐) 1283267 A7Wherein R 1 and R 6 are each a C 6-18, preferably an alkyl or alkenyl group of 8 to 16, more preferably an alkyl group, and R 3 and R 4 are each an alkyl group or a hydroxyalkyl group having 1 to 3 carbon atoms; . X is an aromatic ring or an ester group selected from the group consisting of -COO-, -CONH-, -0C0-, -NHCO- or a guanamine group, and when the R2 system X is an ester group or a guanamine group, the carbon number may be substituted by a hydroxyl group. 1 to 6 of the olefin group, when X is an aromatic ring, it is replaced by a hydroxyl group. The paper scale applies to the Chinese National Standard (CNS) A4 specification (210X297 mm) 1283267 A7

之破數1〜6的晞烴基或气⑴RlV。此處,Rll爲乙烯基或 丙晞基’以乙埽基爲佳,k爲平均1〜1〇,宜爲平均之 數。R5爲碳數丨〜3的烯烴基。r7〜r1〇爲此等之中丄個以 上’且爲1個或2個碳數8〜18,宜爲8〜14,更宜爲8〜12之 燒基,其餘爲碳數i〜3之烷基或羥烷基。又,〇爲〇或1之 數目。進一步γ-爲陰離子,尤其爲鹵素離子、硫酸離子、 碳數1〜3之烷基硫酸離子、碳數^3之烷基所取代的芳香 族磺酸離子。 更佳之(b)成分爲上述通式(丨)或(3)之化合物,最佳爲下 述之通式化合物。 CH〇The number of oxime hydrocarbon groups or gas (1) RlV is broken. Here, R11 is a vinyl group or a propyl group. The ethyl group is preferably an ethyl group, and k is an average of 1 to 1 Å, preferably an average number. R5 is an olefin group having a carbon number of 丨3. R7~r1〇 are more than one or more of these and are 1 or 2 carbon numbers 8 to 18, preferably 8 to 14, more preferably 8 to 12, and the rest are carbon numbers i to 3. Alkyl or hydroxyalkyl. Also, the number is 〇 or 1 number. Further, γ- is an anion, particularly an aromatic sulfonate ion substituted with a halogen ion, a sulfate ion, an alkyl sulfate ion having 1 to 3 carbon atoms, or an alkyl group having 3 carbon atoms. More preferably, the component (b) is a compound of the above formula (丨) or (3), and is preferably a compound of the formula below. CH〇

式中,R表示碳數8〜16之烷基。In the formula, R represents an alkyl group having 8 to 16 carbon atoms.

式中,R亦可爲分枝之碳數6〜12的烷基,瓜表示平均 1〜5的數目。 -13- 本紙乐尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1283267 五、發明説明In the formula, R may also be an alkyl group having a branched carbon number of 6 to 12, and melon means an average number of 1 to 5. -13- The paper music scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1283267 V. Invention description

RR

R /CH3 N xch3 cr 二’版R表不可爲相異的碳數8〜12的烷基。 ⑻成为係本發明之殺菌防污清潔劑中較佳爲請卜30 :量=詳而言之,以觸發器或噴霧器等之嗜霧裝置、 或、如塗布之方法洗淨對象的硬質表面時,#(b)成分之濃 度馬0.001〜5重量%,更宜爲〇〇〇5〜2重量%,另外,在利 用崩所水槽内的水之洗淨方时,於讀内或 通路設有裝置,可於水槽内之水投人適量的洗淨液,^ 此厠所用自動洗淨器時,係含有〇1〜3〇重量%,更宜爲 卜20重量%。又,水槽内之(b)成分的濃度宜爲〇〇i〜i〇 ppm ° 在本發明中,保持充分的防污性上,爲得到殺菌效果, (a)成分/(b)成分就重量比宜爲30^4/50,更宜爲2〇/1 〜1/20,最宜爲1〇/1〜mo。 本發明之硬質表面用殺菌防污清潔劑進一步含有(b )成八 以外之界面活性劑[以下稱爲(c)成分]作爲(c)。界面活1 劑宜添加選自非離子界面活性劑、兩性界面活性劑、@離 子界面活性劑中之1種以上的界面活性劑。 非離子界面活性劑可舉例下述式(c 1)〜式(c 3 )的化人 物。R /CH3 N xch3 cr The two-version R table cannot be a different alkyl group having 8 to 12 carbon atoms. (8) It is preferable to use the sterilizing and antifouling cleaning agent of the present invention as the amount of the smear 30: the amount = in detail, when the surface of the object is cleaned by a fogging device such as a trigger or a sprayer, or by a coating method The concentration of the component #(b) is 0.001 to 5% by weight, more preferably 5% to 2% by weight, and is provided in the reading or passage when using the washing of the water in the sink. The device can inject a proper amount of washing liquid into the water in the water tank. When the automatic washing device for the toilet is used, it contains 〇1 to 3〇% by weight, more preferably 20% by weight. Further, the concentration of the component (b) in the water tank is preferably 〇〇i to i 〇 ppm °. In the present invention, in order to maintain sufficient antifouling property, in order to obtain a sterilizing effect, (a) component/(b) component is weighed. The ratio is preferably 30^4/50, more preferably 2〇/1 〜1/20, and most preferably 1〇/1~mo. The sterilizing and antifouling cleaning agent for hard surfaces of the present invention further contains (b) a surfactant other than (hereinafter referred to as component (c)) as (c). It is preferable to add one or more kinds of surfactants selected from the group consisting of nonionic surfactants, amphoteric surfactants, and @ionic surfactants. The nonionic surfactant can be exemplified by the following formula (c 1) to formula (c 3 ).

Rcl-〇(EO)nH (cl) -14-Rcl-〇(EO)nH (cl) -14-

1283267 A7 _______B7 五、發明説明(12 ) [式中,Rcl爲平均碳數1〇〜2〇,宜爲1〇〜18之一級直鏈 烷基、分枝鏈烷基或二級之烷基。E〇爲環氧乙烷,n係平 均加成莫耳數爲]1283267 A7 _______B7 V. INSTRUCTION DESCRIPTION (12) [wherein, Rcl is an average carbon number of 1 〇 to 2 Å, preferably 1 〇 to 18, a linear alkyl group, a branched alkyl group or a secondary alkyl group. E〇 is ethylene oxide, and the n-type average addition molar number is]

Rc2-0(E0)p/(P0)qH (c2) [式中,R 2爲平均碳數10〜2〇,宜爲1〇〜18之一級烷 基。E0爲環氧乙烷,p〇爲環氧丙烷。上及丨爲平均加成莫 耳數,p爲5〜15,q爲1〜5。E0與p〇係隨機加成或加成 E0後,亦可加成p〇,又,亦可爲如其相反之嵌段加成 體。又,嵌段加成體亦可爲3.個以上之嵌段。]Rc2-0(E0)p/(P0)qH (c2) [wherein R 2 is an average carbon number of 10 to 2 Å, preferably a mono-alkyl group of 1 〇 18 18 . E0 is ethylene oxide and p〇 is propylene oxide. The upper and lower 丨 are the average addition moiré, p is 5 to 15, and q is 1 to 5. E0 and p〇 are randomly added or added to E0, and may be added to p〇, or may be the opposite block addition. Further, the block addition product may be three or more blocks. ]

Rc3-(ORc4)xGy (c3) [式中’ Re3爲直鏈或分枝鏈的碳數8〜18的燒基或具有燒 晞基或碳數8〜18的烷基的烷基苯基、R“爲碳數2〜4之燒 烯基、G爲源自碳數5或6之還原糖的殘基或葡萄糖殘基,χ 爲平均値0〜6的數目,y表示平均値1〜10的數目]。 界面活性劑可舉例以下述通式(c4)所示之胺氧化物及通 式(c5)所τι:之甜菜驗。 rC5 —(ARC6^-Ni-►0 r iC8 -15 - 本紙張尺度適用中國國家標準(CNS) A4規格(210x297公釐) 1283267 A7 B7 五、發明説明(13 式中,Rc)爲碳數8〜18之烷基或烷晞基,R“爲碳數^ 的缔煙基° RC7、8分別爲碳數1〜3的烷基或羥烷基。a 係選自- COO-、-C0NH-、-〇c〇…-NHC〇_、之基,Γ 爲0或1的數目。 (c 5) RC7 rc5 -(arC6^n+-^r«_t r iC8 式中,Rc5、Rc6、Rc7、rc8、A&r係與前述通式(c4) 记載者相同。r。9係亦可被羥基所取代之碳數丨〜5的缔烴 基,T爲選自_〇S〇3-、-C〇〇,、-S〇3·之陰離子基。r爲〇或工 之數目。] 陰離子界面活性劑可舉例:烷基之碳數8〜18的烷基苯磺 酸鹽、烷磺酸鹽、α晞烴磺酸鹽、烷基硫酸酯鹽、聚氧乙 烯基烷基醚硫酸鹽、聚氧乙烯基烷基醚醋酸鹽等。 在本發明中尤其係調配選自前述式(c3)、(c4)、及(c5) 之界面活性劑的一種以上,不會損及防污效果可得到優異 之洗淨性。(C)成分之界面活性劑的調配量爲不損及殺菌及 防污效果,得到充分的洗淨力或起起泡力,宜爲001重量 %以上、50重量%以下、更宜爲〇丨重量%以上,尤宜爲 0.1〜3 0重量% 〇 但,陰離子界面活性劑[以下爲(cA)]爲降低殺菌性及防 污性,應以不影響的量來調配,含有(cA)時,(£人)/(1))就 重量比率爲不超過1.0的量,更宜以不超過〇.75的量來調 -16- 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公釐) 1283267 A7 _— __ _B7 五、發明説明(Μ ) 配。若超過此範圍,無法得到防污及殺菌效果的兩者。 (c)成分於本發明之殺菌防污清潔劑中宜爲〇」〜3 〇重量 %,詳而言之,以觸發器或噴霧器等之噴霧裝置,或如塗 布 <万法直接洗淨對象之硬質表面時,(c)成分之濃度爲 〇·1〜20重量%,更罝爲〇 2〜1〇重量%,另外,在利用廁所 水槽内的水之洗淨方法中,於水槽内或任意之給水通路設 有裝置,可於水槽内之水投入適量的洗淨液,使用於此廁 所用自動洗淨器時,含有〇·5〜3〇重量%, 量❶又,崩所的水槽内之⑷成分濃度宜L;〜20 ppm 〇 在本發明中’就對有機污垢之洗淨力提昇目的,宜調配 水溶性㈣[以下作爲⑷成分]作爲任意成分的成分,宜選 自[1]碳數1〜5的1價醇、[2]碳數4〜12之多價醇、[3]以下 述通式⑷)所示之化合物、⑷以下述通式(d2)所示的化 合物及[5]以下述通式(d3)所示之化合物中的一種以上。Rc3-(ORc4)xGy (c3) [wherein Re3 is a linear or branched chain having 8 to 18 carbon atoms or an alkylphenyl group having a decyl group or an alkyl group having 8 to 18 carbon atoms; R "is an alkyl group having 2 to 4 carbon atoms, G is a residue derived from a reducing sugar having a carbon number of 5 or 6, or a glucose residue, χ is an average number of 値0 to 6, and y is an average 値1 to 10 The number of the surfactants can be exemplified by the amine oxide represented by the following formula (c4) and the beet of the formula (c5): rC5 — (ARC6^-Ni-►0 r iC8 -15 - This paper scale applies to Chinese National Standard (CNS) A4 specification (210x297 mm) 1283267 A7 B7 V. Inventive Note (13 where Rc) is an alkyl or alkane group with a carbon number of 8 to 18, and R is a carbon number. ^ 烟 烟 ° ° RC7, 8 are alkyl 1 or 3 alkyl or hydroxyalkyl, respectively. a is selected from - COO-, -CONH-, -〇c〇...-NHC〇_, the base, Γ The number is 0 or 1. (c 5) RC7 rc5 - (arC6^n+-^r«_t r iC8 where Rc5, Rc6, Rc7, rc8, A&r are the same as those described in the above formula (c4) The same. r. 9 is a hydrocarbon group having a carbon number of 丨~5 which may be substituted by a hydroxyl group, and T is selected from the group consisting of 〇S〇3-, -C〇〇, and -S〇3. Ionic group. r is the number of hydrazine or work.] Anionic surfactants can be exemplified by alkyl benzene sulfonates, alkane sulfonates, alpha sulfonium sulfonates, alkyl sulphates having 8 to 18 carbon atoms in the alkyl group. An ester salt, a polyoxyethylene alkyl ether sulfate, a polyoxyethylene alkyl ether acetate, etc. In the present invention, interfacial activity selected from the above formulas (c3), (c4), and (c5) is especially formulated. One or more kinds of agents can provide excellent detergency without impairing the antifouling effect. The amount of the surfactant of the component (C) is such that the antibacterial and antifouling effects are not impaired, and sufficient detergency or rise is obtained. The foaming force is preferably 001% by weight or more and 50% by weight or less, more preferably 〇丨% by weight or more, particularly preferably 0.1% by weight to 30% by weight. However, the anionic surfactant [hereinafter (cA)] is for reducing sterilization. Sex and antifouling properties should be formulated in an amount that does not affect. When (cA) is contained, (£person)/(1)) is not more than 1.0, and more preferably not more than 〇.75. To adjust-16- This paper scale applies to China National Standard (CNS) A4 specification (210X297 mm) 1283267 A7 _— __ _B7 V. Invention description (Μ) If it exceeds this range, both antifouling and bactericidal effects cannot be obtained. (c) The composition is preferably 〇"~3 〇% by weight in the sterilizing antifouling detergent of the present invention, in detail, with a trigger Or a spray device such as a sprayer, or when the hard surface of the object is directly washed by the coating method, the concentration of the component (c) is 〜·1 to 20% by weight, more preferably 〇2 to 1% by weight, and In the method of washing water in the toilet water tank, a device is provided in the water tank or in any water supply passage, and an appropriate amount of the washing liquid can be put into the water in the water tank, and when the automatic washing device for the toilet is used, The concentration of the component (4) in the water tank containing 〇·5~3〇% by weight, and the amount of collapse is preferably L; ~20 ppm 〇 In the present invention, it is suitable for the purpose of improving the detergency of organic dirt. (4) [The component (4) below] is preferably a component selected from the group consisting of [1] a monovalent alcohol having 1 to 5 carbon atoms, [2] a polyvalent alcohol having 4 to 12 carbon atoms, and [3] having the following general formula (4). ) the compound shown, (4) a compound represented by the following formula (d2), and [5] a compound represented by the following formula (d3) One or more.

RdlO(C2B4〇HC3ii6〇)Rd:1 s t h2c - ch2 R^~N\ /N—Rd4 (d 2) II 一 ο -17-RdlO(C2B4〇HC3ii6〇)Rd:1 s t h2c - ch2 R^~N\ /N-Rd4 (d 2) II a ο -17-

1283267 A7 B7 五、發明説明(15 )1283267 A7 B7 V. Description of invention (15)

Rd5OC(CH3)2CH2CH2OH (d 3) 式中,Rdl及Rd2分別表示氫原子、碳數卜8的烷基、苯 基或苯甲基,但,除去Rdl及Rd2之兩者爲氫原子的情形。 S及t分別表示〇〜1 〇的數目,但,除去S及t之兩者爲〇的情 形。Rd3及Rd4表示碳數i〜3的烷基。Rd5表示碳數1〜3的 燒基。 [1]之碳數2〜5的1價醇一般可舉例乙醇、丙醇、異丙 醇。藉調配此等低級醇,可進一步提昇在低溫之系的安定 性。 [2]之後數4〜12的多價醇,可舉例:異丙醇、22,4-三 甲基-1,3 -戊二醇、ι,5 -戊二醇、;[,8•辛二醇、•壬二 醇、乙二醇、丙二醇、二乙二醇、二丙二醇、甘油外,尚 且垸基之碳數爲3〜8的單烷基甘油基醚。 [3]之化合物在通式(dl)中,Rcu、Rd2爲烷基時的碳數 =1〜4爲尤佳。又,通式(dl)中,環氧乙烷(以下稱e〇)及 環氧丙烷(以下稱P0)之平均加成莫耳數的s&t,分別爲 〇…的數目,但,E0與P0之加成順序無特別限定,而亦 γ爲經隨機加成者。[3]之化合物的具體例可舉出:乙二醇 單丁基醚、二丙二醇二甲基醚、二乙二醚單乙二 二醇單丁基醚、丙二醇單甲基H醇單丙基醚、:二 醇單乙㈣、丙二醇二甲基酸、聚氧乙 烯(平均加成莫耳數=2〜3)聚氧丙(平均加成莫耳數=2 -18- A7 B7Rd5OC(CH3)2CH2CH2OH (d3) wherein Rd and Rd2 each represent a hydrogen atom, an alkyl group having a carbon number of 8, or a phenyl group or a benzyl group, and the case where both of Rdd and Rd2 are a hydrogen atom is removed. S and t respectively represent the number of 〇~1 ,, but the case where both S and t are 〇 is removed. Rd3 and Rd4 represent an alkyl group having a carbon number of i to 3. Rd5 represents a burnt group having a carbon number of 1 to 3. The monovalent alcohol having 2 to 5 carbon atoms in [1] is generally exemplified by ethanol, propanol or isopropanol. By adjusting these lower alcohols, the stability in the low temperature system can be further improved. [2] After the polyvalent alcohol of 4 to 12, for example, isopropanol, 22,4-trimethyl-1,3-pentanediol, iota, 5-pentanediol, [,8•xin A monoalkyl glyceryl ether having a carbon number of 3 to 8 in addition to a diol, a decanediol, ethylene glycol, propylene glycol, diethylene glycol, dipropylene glycol, or glycerin. The compound of [3] is preferably in the formula (d1), and the carbon number of the case where Rcu or Rd2 is an alkyl group is =1 to 4. Further, in the general formula (d1), s&t of the average addition molar number of ethylene oxide (hereinafter referred to as e〇) and propylene oxide (hereinafter referred to as P0) are respectively the number of 〇..., but E0 The order of addition to P0 is not particularly limited, and γ is a random addition. Specific examples of the compound of [3] include ethylene glycol monobutyl ether, dipropylene glycol dimethyl ether, diethyl ether monoethylene diethylene glycol monobutyl ether, and propylene glycol monomethyl H alcohol monopropyl group. Ether, diol monoethyl (tetra), propylene glycol dimethyl acid, polyoxyethylene (average addition mole number = 2 to 3) polyoxypropylene (average addition mole number = 2 -18- A7 B7

1283267 五、發明説明(16 ) 二醇二甲基醚、聚氧乙(平均加成莫耳數=1〜4)二醇苯基 醚、苯基卡必醇、苯基溶纖劑、苯甲基卡必醇等。其中, 就洗淨力及使用感之點而言,宜爲丙二醇單甲基酸、二乙 二醇早丁基醚、聚氧乙(平均加成莫耳數=1〜4)二醇苯基 醚。 又’ [4]之化合物可例示i,3 -二甲基-2-味竣燒明、1 3 二乙基-2-咪咬燒酮爲適宜者,[5]之化合物宜爲3 -甲氧基 3-甲基丁醇、3·乙氧基-3-甲基丁醇等。 其中就對基材之損傷性而言,宜選自[i]、[2]及[3]之化 合物的水溶性溶劑,尤其宜爲選自乙醇、異丙醇、乙二 醇、丙二醇、二乙二醇、二丙二醇、甘油、異丙二醇、丙 二醇單甲基醚、丙二醇單乙基酸、丙二醇單丙基鍵、丙二 醇單丁基醚及燒基之碳數爲3〜8的單燒基縮水甘油基趟之 水溶性溶劑。 (d)成分於本發明之殺菌防污清潔劑中宜爲〇1〜5〇重量 %,詳而言之,以觸發器或噴霧器等之噴霧裝置、或、如 塗布之方法洗淨對象的硬質表面時,(d)成分之濃度爲 0.1〜20重量。/〇,更宜爲〇·5〜10重量%,另外,在利用水槽 内之水的洗淨方法中,於水槽内或任意的給水通路設有裝 置,可於水槽内之水中投入適當的洗淨液,使用此廁所用 自動清洗器時,含有1〜50重量%,更宜含有5〜30重量%。 又,廁所的水槽内之(d)成分濃度宜爲〇·〇1〜20 ppm。 在本發明中,就溶解無機污垢'提昇洗淨力及殺菌效果 之目的,進一步(e)成分宜調配螯合劑。螯合劑宜爲(1)三 -19- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1283267 A7 B7 五、發明説明(17 ) 多元磷酸、焦磷酸、正磷酸、六偏磷酸及此等之鹼金屬 鹽、(2)乙二胺四醋酸、羥亞胺基二醋酸、二羥乙基甘氨 酸、亞硝基三醋酸、羥基乙二胺三醋酸、二乙三胺五醋 酸、三乙四胺六醋酸及此等之驗金屬鹽或驗土族金屬鹽、 (3)胺基三亞甲基膦酸、1-羥基亞乙基-1,1-二膦酸、乙二 胺四亞甲基膦酸、二乙三胺五亞甲基膦酸、胺基三亞曱基 膦酸之N -氧化物及此等之鹼金屬鹽或鹼土族金屬鹽、(4*) 選自丙烯酸及曱基丙烯酸之單體的單一聚合物或共聚合 物、丙晞酸-馬來酸共聚合物、聚經基丙晞酸及其驗金 屬鹽、(5)轉樣酸、號拍酸、蘋果酸、反丁晞二酸、酒石 酸、丙二酸、馬來酸之多價羧酸及選自其等之鹼金屬鹽之 一種以上、(6)烯基甘氨酸-Ν,Ν-二醋酸、天冬氨酸·Ν,ν_ 二醋酸、絲氨酸·Ν,Ν·二醋酸、穀氨酸二醋酸、乙二胺二 琥拍酸或其等之鹽,尤以(2)、(3)、(5)之化合物爲佳。 (e)成分在本發明之殺菌防污清潔劑中宜爲〇1〜2〇重量 %,更詳而言之,觸發器或噴霧器等之噴霧裝置、或如塗 布之方法洗淨對象之硬質表面時,(e)成分之濃度爲 0.1〜10重量%,更宜爲〇.3〜7重量%,另外,在利用廁所水 槽内之水的洗淨方法中,於水槽内或任意的給水通路設有 裝置’可於水槽内之水投入適當的洗淨液,使用此廁所用 自動清洗淨器時,係含有1〜2 〇重量%,更宜含有2〜2 〇重 量。/〇。又’廟所的水槽内的成分濃度宜爲〇 〇1〜2〇 ppm ° 一 本發明當凋整PH時亦可使用pH調整劑。pH調整劑亦可 -20- 本纸張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1283267 A7 __—____B7 _ 五、發明説明(18 ) 使用鹽酸或硫酸等無機酸、或檸檬酸、號始酸、顏果酸、 反丁晞二酸、酒石酸、丙二酸、馬來酸等之有機酸等的有 機酸等之酸劑、或、氫氧化鈉或氫氧化鉀、氨水、或其衍 生物、單乙醇胺或二乙醇胺、三乙醇胺等之胺鹽等、唆酸 鈉碳酸舞等之驗劑,可單獨或複合使用。又,亦可使此 等之酸劑與鹼劑組合而使用來作爲緩衝劑系。 本發明之硬表面用殺菌防污清潔劑藉上述之pH調整劑宜 调整成pH在20 C下爲2〜12 ’尤其pH爲3〜11,防;ί*亏效果爲 佳。 、. 在本發明中,就擁有使用時之附著性、易使用性提昇之 目的’可添加水溶性高分子的i種以上,水溶性高分子無 特別限定,但宜選自特開平8-2〇9194碎公報6頁1〇襴〜7頁 1 1欄之水溶性高分子的1種以上。 在本發明之硬表面殺菌防污清潔劑中,上述成分外,在 不抽及本發明效果之範圍,亦添加一般清潔劑所調配之添 加劑、例如香料、抗菌劑、黏度調整劑、顏料、染料、懸 濁知彳等。又,就提咼使用時之起泡性,可添加選自甲苯橫 酸、二甲苯確酸、異丙苯磺酸、烷烯基琥珀酸及此等鹼金 屬鹽等之起泡助劑的1種以上。 使用本發明時,亦可使(&)成分之聚合物與〇)成分之殺 菌化合物溶解或分散於溶劑中成爲一劑,以任意成分組合 而成的任意劑數。又,組合任意成分,對於水等之溶劑而 立即溶解或賦予徐放性,以一劑-以上之粉末或錠劑的形狀 來使用。進而,亦可以(a)成分與(b)成分或任意成分之任 -21 - 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公|) 1283267 A7 ___B7 五、發明説明(19 ) 一者爲液狀,其他爲粉末等之固體狀來使用。 本發明之殺菌防污清潔劑使用時的形態,並無特別,但 宜含有(a)成分、(b)成分及任意成分,其餘部分爲水之液 體組合物,使用來作爲自動清淨器時,係使用聚乙二醇、 聚乙二醇脂肪酸酯、聚乙二醇脂肪酸二酯、脂肪酸、或鹽 等之凝固劑而成爲固體狀或凝膠狀的組合物。水之含量係 當液體組合物或凝膠狀組合物時宜爲1〇〜98章量%、更宜 爲2 0〜95重量%。當固體狀組合物時宜爲3〇%以下,更宜 爲2 0%以下。 實施例 調製表1所示之組成的殺菌防污清潔劑,有關其防污性及 殺菌性以下述之方法來評估。結果表示於表1中。 <防污性之評估〉 % (1)易洗淨性 將殺菌防污劑1 ml塗布於面積10 em2之陶器磁磚表面, 放置5分鐘後,水200 ml以45。角度流速25 ml/秒的比率流 動,再使之乾燥,反覆進行5次後,於陶器磚器表面呈點 狀滴下油酸0.5 g。滴下油酸之陶器磁磚,使油酸不流動 狀,靜置於水槽的底,水不直接施加於陶器磁磚,靜靜地 於水槽水充滿下,判定此時之油酸從陶器磁磚表面被除去 之面積的比率,以如下之5階段進行.評估。又,防污掉落 之%採用模型污染板5片的平均値。 5 :污垢掉落爲8 0 %以上。 _ 4 :污垢掉落爲6 0 %以上8 0 %以下。 -22- 1283267 A7 B7 - --- 五、發明説明(2〇 ) 3 :污垢掉落爲40%以上60%以下。 2 :污垢掉落爲2〇%以上40%以下。 1 :污垢掉落爲2 0 %以下。 (2)污垢附著防止性 使用市售之便器(C730B、柬陶機器(股)製),進行污垢 附著難易之評估。亦即,以組合物洗淨便器,放置i週時 之污垢的附著難易,依據以下之基準以肉眼進行測定。 (評估基準) ◎:丨亏垢未附著。 〇:污垢略附著。 △ ••污垢很少附著。 X ··污垢附著很多。 <殺菌性評估> 使用大腸菌(Escherichia Coli : IF03972)與黃色葡萄球菌 (Staphylococcus aureus : IF012732)作爲供試菌。 殺菌性試驗係於表1所示之殺菌防污劑2 ml中加入丨〇 8〜 1 〇個之細菌浮遊液5 0 a 1 ’充分混合後,調查放置5分鐘 時之设菌性。放置後,採取其混合液〇 1 ml而加入於〇 9 之L P稀釋液中,充分混合,降低洗淨液對菌之影響,然 後,將此混合液塗布於SCDLP瓊脂培養基上,大腸菌在37 C下培養2 4小時,黃色葡萄球菌在3. 7 π下培養4 8小時。 計算培養後所生育的菌落數。又,殺菌試驗係對於相同之 殺菌防污劑,每一各別放置時間分別以5個試驗區來實 施,以下之評點來評估殺菌性。 -23-1283267 V. Description of Invention (16) Glycol dimethyl ether, polyoxyethylene (average addition molar number = 1 to 4) glycol phenyl ether, phenyl carbitol, phenyl cellosolve, benzo Kikabi alcohol and the like. Among them, in terms of detergency and feeling of use, it is preferably propylene glycol monomethyl acid, diethylene glycol early butyl ether, polyoxyethylene (average addition molar number = 1 to 4) diol phenyl ether. Further, the compound of [4] can be exemplified by i, 3-dimethyl-2-butyrene, 1 3 diethyl-2-carbobutyl ketone, and the compound of [5] is preferably 3-A. Oxy 3-methylbutanol, 3·ethoxy-3-methylbutanol, and the like. The water-soluble solvent of the compound selected from [i], [2], and [3], particularly preferably selected from the group consisting of ethanol, isopropanol, ethylene glycol, propylene glycol, and the like. Ethylene glycol, dipropylene glycol, glycerin, isopropyl glycol, propylene glycol monomethyl ether, propylene glycol monoethyl acid, propylene glycol monopropyl bond, propylene glycol monobutyl ether and a single alkyl group with a carbon number of 3 to 8 A water-soluble solvent of glyceryl hydrazine. The component (d) is preferably 〇1 to 5 〇% by weight in the sterilizing and antifouling cleaning agent of the present invention, and in detail, the object is washed by a spray device such as a trigger or a sprayer, or by a coating method. When the surface is used, the concentration of the component (d) is 0.1 to 20 parts by weight. /〇, more preferably 5 to 10% by weight, and in the washing method using the water in the water tank, a device is provided in the water tank or in any water supply passage, and the water can be appropriately washed in the water in the water tank. The cleaning solution, when using the automatic cleaner for the toilet, contains 1 to 50% by weight, more preferably 5 to 30% by weight. Further, the concentration of the component (d) in the water tank of the toilet is preferably 1 to 20 ppm. In the present invention, in order to dissolve the inorganic soil to enhance the detergency and the bactericidal effect, the further component (e) is preferably formulated with a chelating agent. The chelating agent should be (1) 3-19- This paper scale is applicable to China National Standard (CNS) A4 specification (210X 297 mm) 1283267 A7 B7 V. Invention description (17) Polyphosphoric acid, pyrophosphoric acid, orthophosphoric acid, six partial Phosphoric acid and alkali metal salts thereof, (2) ethylenediaminetetraacetic acid, hydroxyiminodiacetic acid, dihydroxyethylglycine, nitrostriacetic acid, hydroxyethylenediaminetriacetic acid, diethylenetriaminepentaacetic acid , triethylenetetramine hexaacetic acid and the metal salt or soil test group metal salt, (3) aminotrimethylene phosphonic acid, 1-hydroxyethylidene-1,1-diphosphonic acid, ethylenediamine four a methylene phosphonic acid, a diethylenetriamine penta methylene phosphonic acid, an N-oxide of an aminotrimethylene phosphonic acid, and an alkali metal or alkaline earth metal salt thereof, (4*) selected from the group consisting of acrylic acid and Single polymer or copolymer of methacrylic acid monomer, propionate-maleic acid copolymer, polypyridyl citrate and its metal salt, (5) transgenic acid, calo acid, apple (1) an alkenyl glycine-ruthenium, an anthracene-acid, a carboxylic acid, a malonic acid, a malonic acid, a polyvalent carboxylic acid, or an alkali metal salt selected from the group consisting of Diacetate, aspartic acid, hydrazine, ν_ diacetic acid, serine, hydrazine, hydrazine diacetate, glutamic acid diacetic acid, ethylenediamine bis-succinic acid or the like, especially (2), (3 The compound of (5) is preferred. The component (e) is preferably 〇1 to 2% by weight in the sterilizing antifouling detergent of the present invention, and more specifically, a spray device such as a trigger or a sprayer, or a hard surface for washing the object as a coating method The concentration of the component (e) is 0.1 to 10% by weight, more preferably 3% to 7% by weight, and in the washing method using the water in the toilet tank, the water tank or any water supply passage is provided. There is a device that can put a proper cleaning solution into the water in the water tank. When using the automatic cleaning device for the toilet, it contains 1 to 2% by weight, more preferably 2 to 2 inches. /〇. In addition, the concentration of the components in the water tank of the temple should be 〇 〇 1~2 〇 ppm °. The pH adjuster can also be used when the pH of the invention is reduced. pH adjuster can also be -20- This paper scale is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) 1283267 A7 __-____B7 _ V. Invention description (18) Use inorganic acid such as hydrochloric acid or sulfuric acid, or An acid such as an organic acid such as an organic acid such as citric acid, succinic acid, anaphoric acid, succinic acid, tartaric acid, malonic acid or maleic acid, or sodium hydroxide or potassium hydroxide or ammonia Or a derivative thereof, an amine salt such as monoethanolamine or diethanolamine or triethanolamine, or a test agent such as sodium citrate carbonate dance, may be used singly or in combination. Further, these acid agents may be used in combination with an alkali agent as a buffer system. The sterilizing and antifouling cleaning agent for hard surfaces of the present invention should be adjusted to a pH of 2 to 12 ′ at 20 C, especially at a pH of 3 to 11 by the above-mentioned pH adjusting agent, and it is preferable that the effect is low. In the present invention, the water-soluble polymer may be added for the purpose of improving the adhesion and ease of use at the time of use. The water-soluble polymer is not particularly limited, but is preferably selected from the group consisting of 〇 4 4 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 In the hard surface sterilizing antifouling detergent of the present invention, in addition to the above components, additives which are formulated with general detergents, such as perfumes, antibacterial agents, viscosity modifiers, pigments, dyes, are also added without extracting the effects of the present invention. Suspended knowledge and so on. Further, in order to improve the foaming property at the time of use, a foaming auxiliary agent selected from the group consisting of toluic acid, xylene acid, cumenesulfonic acid, alkenyl succinic acid, and the like may be added. More than one species. In the case of using the present invention, the bactericidal compound of the (&) component and the bactericidal compound of the hydrazine component may be dissolved or dispersed in a solvent to form a single agent, and any number of components may be combined. Further, the components are combined and dissolved or imparted with a solvent such as water, and used in the form of one or more powders or tablets. Furthermore, it is also possible to apply the Chinese National Standard (CNS) A4 specification (210 X 297 public |) 1283267 A7 ___B7 to the (a) component and the component (b) or any component. The invention specification (19) One is liquid, and the other is a solid such as a powder. The sterilizing antifouling detergent of the present invention is not particularly preferred in the form of use, but preferably contains the component (a), the component (b), and an optional component, and the remainder is a liquid composition of water, and when used as an automatic cleaner, A solid or gel-like composition is used by using a coagulant such as polyethylene glycol, polyethylene glycol fatty acid ester, polyethylene glycol fatty acid diester, fatty acid or salt. The content of water is preferably from 1 to 98% by weight, more preferably from 20 to 95% by weight, based on the liquid composition or the gel composition. When the solid composition is used, it is preferably 3 % by weight or less, more preferably 20% or less. EXAMPLES A sterilizing antifouling detergent having the composition shown in Table 1 was prepared, and its antifouling property and bactericidal property were evaluated by the following methods. The results are shown in Table 1. <Evaluation of antifouling property> % (1) Washability 1 ml of a bactericidal antifouling agent was applied to the surface of a ceramic tile having an area of 10 em2, and after standing for 5 minutes, water was 200 ml to 45. The flow rate of the angular flow rate was 25 ml/sec, and it was dried. After repeated 5 times, 0.5 g of oleic acid was dropped on the surface of the pottery brick. Drip the oleic acid pottery tiles so that the oleic acid does not flow, and it is placed at the bottom of the sink. The water is not directly applied to the pottery tiles, and it is quietly filled with water in the sink to judge the oleic acid from the pottery tiles. The ratio of the area where the surface was removed was evaluated in the following five stages. Further, the % of the antifouling drop is the average enthalpy of the five pieces of the model contamination plate. 5: The dirt falls to more than 80%. _ 4 : The dirt falls to 60% or more and 80% or less. -22- 1283267 A7 B7 - --- V. Description of invention (2〇) 3 : The dirt falls to 40% or more and 60% or less. 2: The dirt falls to 2% or more and 40% or less. 1 : The dirt falls below 20%. (2) Prevention of dirt adhesion The use of a commercially available toilet (C730B, manufactured by Kaneka Machine Co., Ltd.) was used to evaluate the difficulty of adhesion of dirt. In other words, the toilet was washed with the composition, and it was difficult to adhere the dirt at the time of the i week, and the measurement was carried out visually according to the following criteria. (Evaluation criteria) ◎: The scale was not attached. 〇: The dirt is slightly attached. △ •• The dirt is rarely attached. X ··The dirt is attached a lot. <Bactericidal evaluation> Escherichia Coli (IF03972) and Staphylococcus aureus (IF012732) were used as test bacteria. In the bactericidal test, 2 ml of the bactericidal antifouling agent shown in Table 1 was added to the bacteria floating liquid 5 a 1 ' of 丨〇 8 to 1 and thoroughly mixed, and the bacteriostatic property was set for 5 minutes. After placing, take 1 ml of the mixture and add it to the LP dilution of 〇9, mix well, and reduce the effect of the washing solution on the bacteria. Then, apply the mixture on SCDLP agar medium, coliform at 37 C. The culture was carried out for 24 hours, and the Staphylococcus aureus was cultured at 3.7 π for 48 hours. The number of colonies that were born after the cultivation was counted. Further, the sterilizing test was carried out for each of the same sterilizing and antifouling agents in five test zones, and the following evaluations were used to evaluate bactericidal properties. -twenty three-

96· 96· Γ:..Γ96· 96· Γ:..Γ

I2832ffc°^專利申請案 甲文成明書替換頁(96年4月) --------- 五、發明説明(21 又’則述規定以外之實驗條件的詳細係依據殺菌防黴手 冊(日本防菌防黴學會編、技報堂出版)之p686記載的浮遊 試驗法(定量檢查法)。 〇 :放置時間為5分鐘的菌落數在1 〇 4以下。 X :放置時間為5分鐘的菌落數超過丨〇 4。 表中之成分為如下般。 •聚合物B : Merquat (Υ — π —卜)550[氯化二烯丙基二 甲基銨與丙烯醯胺(莫耳比3〇/7〇)共聚合物(Calg〇n社 製、重量平均分子量5〇〇萬、以凝膠滲透色層分析來測 定,使用聚乙二醇作為標準)] •聚合物A : Merquat ( Y — 口 一卜)i〇〇 [氯化二烯丙基二 甲基铵之均聚聚合物(Calgon社製、重量平均分子量4〇 萬、凝膠滲透色層分析來測定,使用聚乙二醇作為標準)] •聚合物 C : Merquat ( Y — π -卜)280、Calgon 社製、 鼠化一晞丙基二甲基錄與丙晞酸之共聚合物 •聚合物D :於丙烯酸3.59 g、水280 g、3 5 %鹽酸水溶 液3 2 m 1的溶液中冷卻下添加n,N _二甲基胺基丙基甲基 丙烯酸醯胺76.41 g經中和的溶液加熱至7〇它,氮氣下 滴下聚合啟始劑(和光純藥製V - 5 0 )。熟成後冷卻,得 到有效成分18 %之聚合物、重量平均分子量4〇萬、單 體/ [單體(a) +單體(b) ] = 0 · 9莫耳比) •殺菌性化合物A :廿二V° —小[可可烷基二甲基苯甲基 銨氯化物(花王(股)製)] •殺菌性化合物B :〕一少$ V D 10P [二癸基二甲基銨氯 -24 - 本紙張尺度適用中國國家標準(CNS) Α4規格(210X 297公釐) 1283267 A7 B7 發明説明(22~~ 化物(花王(股)製)] • 殺囷性化合物C ·氣化\ y七卜二々a[和光試藥、 述構造的陽離子化合物] (ch3)3cch2c(ch3)2I2832ffc ° ° Patent Application A Wenming Book Replacement Page (April 1996) --------- V. Invention Description (21 also 'Details> The details of the experimental conditions are based on the sterilization and anti-mildew manual The floating test method (quantitative test method) described in p686 (published by the Japan Society for the Prevention of Bacterial and Antimicrobial Diseases), 〇: The number of colonies with a standing time of 5 minutes is less than 1 〇 4. X: Colonies with a standing time of 5 minutes The number exceeds 丨〇 4. The ingredients in the table are as follows: • Polymer B: Merquat (Υ — π — Bu) 550 [diallyldimethylammonium chloride and acrylamide (Morby 3〇/ 7〇) Copolymer (manufactured by Calg〇n, weight average molecular weight 50,000, measured by gel permeation chromatography, using polyethylene glycol as standard)] • Polymer A: Merquat (Y-mouth Ib) i均 [homopolymer of diallyldimethylammonium chloride (manufactured by Calgon, weight average molecular weight 40,000, gel permeation chromatography, using polyethylene glycol as a standard) )] • Polymer C: Merquat (Y — π - Bu) 280, manufactured by Calgon, ratified with propyl propyl Co-polymer of base and propionic acid • Polymer D: n,N-dimethylaminopropyl was added under cooling in a solution of 3.59 g of acrylic acid, 280 g of water, and 3 2 ml of aqueous hydrochloric acid solution of 3 2 m 1 76.41 g of decylamine methacrylate was heated to 7 Torr in a neutralized solution, and a polymerization initiator (V - 50 from Wako Pure Chemical Industries, Ltd.) was added dropwise under nitrogen. After curing, it was cooled to obtain a polymer and weight of 18% of the active ingredient. Average molecular weight of 40,000, monomer / [monomer (a) + monomer (b)] = 0 · 9 mole ratio) • bactericidal compound A: 廿2 V° - small [cocoalkyl dimethyl benzene Methylammonium chloride (King) (manufactured by Kao): • Bactericidal compound B:] Less than $VD 10P [Dimercaptodimethylammonium chloride-24 - This paper scale applies to China National Standard (CNS) Α4 specification ( 210X 297 mm) 1283267 A7 B7 Description of the invention (22~~ compound (King)) • Acaricidal compound C · gasification \ y 7 Bu 々 a [and photochemical reagents, cationic compounds of the structure] (ch3)3cch2c(ch3)2

Cl. • 殺菌性化合物D :氯化辛基二甲基芊烷銨 • AD ·· r y t卜一々20N[月桂基二甲基胺氧化物(花王 (股)製)] • AG ··垸基葡萄糖苷(直鏈烷基之碳數爲12與14的混合 物、糖平均縮合度1.2[縮合度1與2之毫莫耳)]) • ES : E0平均加成莫耳數爲22莫耳的聚氧乙烯基月桂 基醚硫酸 •甜菜鹼:N-月桂醯基胺基丙基_N,N•二曱基—N.羧基 甲基銨甜菜鹼 • EDTA-4Na :乙二胺四醋酸四鈉鹽 p Η 〃周整如·鹽酸及/或氲氧化鋼(任一者以水溶液使用) 〈實施例2> . 凋整表2所tf之廁所用自動洗淨器組成‘,如括弧内之數 値(ppm)般,以點投入廁所水槽内,有關沖水時之防污性 以下述之方法進行評估。結果表示於表2中。 -25-Cl. • bactericidal compound D: octyl dimethyl decyl ammonium chloride • AD · ryt 々 々 20N [lauryl dimethylamine oxide (King) (manufactured by Kao)) • AG · thioglycol Glycosides (linear alkyl groups with a carbon number of 12 and 14 mixtures, average sugar condensation degree 1.2 [condensation degrees 1 and 2 millimoles)]) • ES: E0 average addition moles of 22 moles of poly Oxyethylene vinyl lauryl ether sulfate • Betaine: N-lauroylaminopropyl _N, N•dimercapto-N. carboxymethylammonium betaine • EDTA-4Na: ethylenediaminetetraacetic acid tetrasodium salt p Η 〃 整 · · 盐酸 HCl HCl HCl 酸 酸 酸 酸 酸 酸 酸 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 〈 In the case of (ppm), the point is put into the toilet sink, and the antifouling property at the time of flushing is evaluated by the following method. The results are shown in Table 2. -25-

1283267 A7 B71283267 A7 B7

<防污性之評估> (1) 易洗淨性 使用沖水10次後之便器(C730B、東陶機器(股)製),將 油酸g呈點狀滴下5處’展除去經沖水後之油酸的面 積比率,以如下之5階段進行評估。χ,污垢掉落之評估 採用5次之平均値。 (評估標準與表1相同) (2) 污垢附著防止性 使用市售之便器(C730B、東陶機器(股)製),評估污垢 附著難易。亦即,以組合物洗淨便器,依以下之基準以肉 眼測定放置1週時之污垢附著難易。 (評估基準) ◎ 污垢未附著 〇 污垢略附著 △ 污垢很少附著 X 污垢附著很多 (3 )細菌之發育抑制效果 於調整成表2之括弧内濃度的組合物2 ml中加入一調整成<Evaluation of antifouling property> (1) Washability After using the flushing device 10 times (C730B, Toto Machinery Co., Ltd.), the oleic acid g was dropped in 5 points. The area ratio of oleic acid after flushing was evaluated in the following five stages. χ, the evaluation of the dirt drop is based on the average of 5 times. (Evaluation criteria are the same as in Table 1.) (2) Prevention of dirt adhesion Using a commercially available toilet (C730B, Toto Machinery Co., Ltd.), it is difficult to assess the adhesion of dirt. Namely, the toilet was washed with the composition, and the adhesion of the dirt at the time of one week was measured by the naked eye on the basis of the following criteria. (Evaluation criteria) ◎ The dirt is not attached 〇 The dirt is slightly attached △ The dirt is rarely attached X The dirt is attached a lot (3) The developmental inhibition effect of the bacteria is adjusted to 2 ml of the composition adjusted to the concentration in the brackets of Table 2

104 cfu/ml 之 Staphylococcus aureus 的懸濁液 0.05 ml 與 SCD 培養基0.1 ml,充分攪拌,在37。(:下靜置18小時,如以下 之式求取靜菌活性値。 又,使用滅菌水作爲空白。 靜菌活性値=1〇g (空白之培養後的生菌數)-log (評估試樣培 養後的生菌數) -26- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1283267 A7 B7 五、發明説明(24 ) 〈評估〉 〇 :靜菌活性値:比0還大 X :靜菌活性値:0以下 -27- 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公釐) 1283267 A7 B7 五、發明説明(25 )A suspension of 104 cfu/ml Staphylococcus aureus 0.05 ml with 0.1 ml of SCD medium, stir well, at 37. (: Let stand for 18 hours, and obtain the bacteriostatic activity as follows. Also, use sterile water as a blank. Static activity 値=1〇g (number of bacteria after blank culture)-log (evaluation test) Number of bacteria after sample culture) -26- This paper scale applies to China National Standard (CNS) A4 specification (210X 297 mm) 1283267 A7 B7 V. Invention description (24) <Evaluation> 〇: Static activity 値: ratio 0 is also large X: static activity 値: 0 or less -27- This paper scale applies to China National Standard (CNS) A4 specification (210X297 mm) 1283267 A7 B7 V. Invention description (25)

硬質表面用殺菌防污清潔劑 銪 調配成分(重量%) 1 1 s 1 1 D&gt; =? 葙 m 〇 &gt; 1 公 2 Q) 钸 热 黑l· l· o 恭 SI &gt; 〇 &gt; 0 Η 薛 CT D&gt; 签 〇 Η H? 〇 因 H? CT 〇&gt; 兹 m m H? CT D&gt; 豸 &gt; 命 ο 命 η 00 &gt; 〇 〇 b Ο CJ ro CJ CJ - - •Ο P 〇 ◎ cn •ο ο CJ ro CO 一 CO S δ P0 〇 ◎ pi 二 ο 漭 C3 ro cn o 'u\ 一 - - ω ο ◎ cn CO § Ol &lt;J1 - - - - CO .公 〇 〇 ’〇 ο 一 CO 一 - ρ ρ CJI ο ◎ ϋΐ ο -* o - S S ο ο ◎ •cn ο 海 i. 一 cn 一 S 一 0 ◎ cn b ο 漭 一 CO S 一 - CJ 00 〇 〇 α&gt; ο N3 N&gt; CJ ro 一 一 - ρ ο s Ρ (0 〇 ◎ ο fO ro Ol 一 一 ro 2 • ·〇 CJ «α ο ο ◎ 1 一 CO 一 S - —A 〇 ◎ cn 〇 ο cn cn - 一 •ο - Γ0 〇 ◎ S: CO 8 漭 者 各 CJ% 一 - 一 - ω 〇 ◎ 办 o ο 海 N3 ro cn 一 一 - - 〇 ◎ Cn ·〇 ο 漭 rsj ro cn S - ρ - «Λ σι ο ◎ ΟΊ ο 海 含; ro ro CO Nd - 一 CJ 0) 〇 〇 ο 者 CO ro cn 一 - ρ ρ 〇 〇 isa o ο 告 ai CJI S - - 00 〇 ◎ cjy σ&gt; ο CJ ro cn -* - ο S cn 〇 ◎ cn b o ο 漭 CJ ro 殘 部, CJ ro S 一 S N3 CJ ro 〇 X &gt; rsj ·〇 ο - X X ·〇 ο - cn •S 一 - ρ ro X &gt; ro O ο - cn CJ S «α ω X X ro 〇 ο 漭 ro ro cn - a 〇 X ro •O ο CO ro cn S 一 ϋΐ X X ro ·〇 ο :海 cn CJ1 一 一 一 Ο) X X fO ο ro fO cn - 一 - 、ι Μ·δο*2 rrtftsse.令J -28-Solid surface sterilizing antifouling detergent 铕 compounding component (% by weight) 1 1 s 1 1 D&gt; =? 葙m 〇&gt; 1 male 2 Q) 钸热黑 l· l· o 恭SI &gt;〇&gt; 0薛 Xue CT D&gt; Signature H? 〇 H H? CT 〇&gt; 兹mm H? CT D&gt;豸&gt; 命ο η 00 &gt; 〇〇b Ο CJ ro CJ CJ - - •Ο P 〇◎ Cn ο ο CJ ro CO a CO S δ P0 〇 ◎ pi 二ο 漭C3 ro cn o 'u\ 一- - ω ο ◎ cn CO § Ol &lt;J1 - - - - CO . 公〇〇'〇ο A CO--ρ ρ CJI ο ◎ ϋΐ ο -* o - SS ο ο ◎ • cn ο sea i. a cn a S a 0 ◎ cn b ο 漭 a CO S a - CJ 00 〇〇α&gt; ο N3 N&gt CJ ro 一一- ρ ο s Ρ (0 〇 ◎ ο fO ro Ol 一一ro 2 • ·〇CJ «α ο ο ◎ 1 A CO A S - A 〇 ◎ cn 〇ο cn cn - one • ο - Γ0 〇◎ S: CO 8 漭CJ% one-one- ω 〇◎ o ο海 N3 ro cn 一一- - 〇◎ Cn ·〇ο 漭rsj ro cn S - ρ - «Λ σι ο ◎ ΟΊ ο 海含; ro ro CO Nd - one CJ 0) 〇〇ο 者 CO ro cn一 - ρ ρ 〇〇isa o ο 告 ai CJI S - - 00 〇 ◎ cjy σ&gt; ο CJ ro cn -* - ο S cn 〇 ◎ cn bo ο 漭CJ ro Remnant, CJ ro S a S N3 CJ ro 〇 X &gt; rsj ·〇ο - XX ·〇ο - cn •S a - ρ ro X &gt; ro O ο - cn CJ S «α ω XX ro 〇ο 漭ro ro cn - a 〇X ro •O ο CO Ro cn S 一 ϋΐ XX ro ·〇ο :海cn CJ1 一一一Ο) XX fO ο ro fO cn - one - , ι Μ·δο*2 rrtftsse. order J -28-

本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1283267 A7 B7 五、發明説明(26 )This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1283267 A7 B7 V. Invention description (26)

表2 調配例 比較調配例 21 22 23 18 S V© 1? (a)成分 7 - 卜280聚合物C 3(1) 5(5) 7卜、一/D 10(10) ⑹成分 廿二殺菌A 3(1) 5(5) ' 〕-^&gt;D10P B 5(5) (c)成分 AO 10(3.3) 10(10) 20(20) AG 10(10) 10(10) 離子交換水 殘部 殘部. 殘部 殘部 合計 100 100 100 100 pH(20°G4 7 7 7 7 易* 5.0 5.0 5.0 .2.0 污垢兔茅择正枉 1 〇 ◎ ◎ X 細菌之發育抑制效果 〇 〇 〇 XTable 2 Preparation examples Comparative preparation example 21 22 23 18 SV© 1? (a) Component 7 - Bu 280 polymer C 3 (1) 5 (5) 7 Bu, a / D 10 (10) (6) Ingredients 3(1) 5(5) ' 〕-^&gt;D10P B 5(5) (c) Component AO 10(3.3) 10(10) 20(20) AG 10(10) 10(10) Ion exchange water residue Residual parts. Residual parts total 100 100 100 100 pH (20°G4 7 7 7 7 Easy* 5.0 5.0 5.0 .2.0 Dirt rabbits Moss 枉 1 〇 ◎ ◎ X Bacterial development inhibition effect 〇〇〇 X

裝 訂Binding

-29 -本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)-29 - The paper size applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm)

Claims (1)

12832紹〇12〇399號專利申請案 中文申請專利範圍替換本(96年4月)12832 Shaohao 12〇399 Patent Application Case Chinese Patent Application Range Replacement (April 1996) 1. 一種硬質表面用殺菌防污清潔劑,其包含 (a)0.01〜30重量%之聚合物,其重量平均分子量為 1,000〜6,000,0〇〇,包含單體單元a,其具有至少一 種選自4級銨基及3級胺基之基;及單體單元B,其 係選自下述(i)〜(v)所組成之群中之至少一種單體; 其中單體單元A/[單體單元A +單體單元B]之莫耳比 為0.4-0.99且單體單元A與出自下述之單體之單 m單元B ’之合計量相對於全單體單元為5 〇〜丨〇〇莫耳 % : (i) 含有陰離子基之化合物,其係選自丙晞酸或其 鹽、甲基丙婦酸或其鹽、馬來酸或其鹽、馬來 酸酐、苯乙烯磺酸鹽、磺基丙基甲基丙烯酸 酯、2 -丙錦r醯胺_2_甲基丙磺酸或其鹽、及磷 酸單-ω -甲基丙晞醯氧烷基(碳原子數 1〜12); (Π )含有醯胺基之化合物,其係選自丙婦醯胺、 Ν,Ν -二甲基胺基丙基丙蹄酸(或甲基丙晞酸) 醯胺、Ν,Ν·二甲基丙烯基(或甲基丙婦基)醯 胺、Ν,Ν-二甲基胺基乙基丙烯酸(或甲基丙烯 酸)醯胺、Ν_乙烯基-2 -己内醯胺及Ν -乙烯基-2-吡咯酮; (iii)含有酯基之化合物,其係選自丙烯酸(或甲基 丙烯酸)烷基(碳數1〜5)、丙婦酸(或曱基丙烯 酸)2-羥乙基、丙烯酸(或甲基丙烯酸 73247-960427.DOC - 1 - 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 8 8 8 8 A B c D 1283267 六、申請專利範圍 二甲基胺基烷基(碳數1〜5 )及乙酸乙烯酯; (iv)選自乙烯、丙嫦、Ν· 丁烯、異丁婦、N -戊 烯、異戊間二烯、2 ·曱基-1 - 丁烯、Ν-己烯、 2 -甲基-1-戊烯、3 -甲基-1-戊烯、4 -甲基-1-戊烯、2 _乙基_ 1 - 丁埽、苯乙烯、乙烯基甲 苯、α -甲基苯乙烯、烯丙基胺、ν,Ν-二烯丙 基胺、Ν 5 Ν -二烯丙基-Ν -烷基(碳數1〜5 )胺、 環氧乙烷、環氧丙烷、2 -乙烯基吡啶及4 -乙 烯基吡啶之化合物;及 (ν) 氣化硫, (b) 0 · 〇 〇 1〜3 〇重1 %之殺適性化合物,其係分子量為 1,000以下且具有4級銨基者;及 (c) 0·0 1〜5〇重量%之界面活性劑; 且含有(cA)陰離子界面活性劑作為界面活性劑時, (c A)/(b)為重量比率不超過1.0。 2.根據申請專利範圍第丨項之硬質表面用殺菌防污清潔劑, 其中(b)乃至少一種選自下述式(1)〜(3)所示化合物之殺 菌性化合物 R1 —( X—R2 ) R3 I R· Ό (1) -2 73247-960427.DOC 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) !283267 ABCD Rb—NA hard surface sterilizing antifouling detergent comprising (a) 0.01 to 30% by weight of a polymer having a weight average molecular weight of 1,000 to 6,000,0 Å, comprising a monomer unit a having at least a group selected from the group consisting of a 4-stage ammonium group and a 3-stage amine group; and a monomer unit B selected from at least one monomer selected from the group consisting of (i) to (v); wherein the monomer unit A The molar ratio of / [monomer unit A + monomer unit B] is from 0.4 to 0.99 and the total amount of monomer unit A and single m unit B ' from the monomer described below is 5 相对 relative to the all monomer unit. ~丨〇〇莫耳% : (i) An anionic group-containing compound selected from the group consisting of propionic acid or a salt thereof, methyl acetoacetic acid or a salt thereof, maleic acid or a salt thereof, maleic anhydride, styrene Sulfonate, sulfopropyl methacrylate, 2-propanyl ruthenium-2-methylpropanesulfonic acid or a salt thereof, and mono-omega-methylpropoxyalkyl phosphate (carbon number) 1~12); (Π) a compound containing a guanamine group, which is selected from the group consisting of butylamine, hydrazine, hydrazine-dimethylaminopropylpropionic acid (or methacrylic acid) decylamine, hydrazine Ν·Dimethylpropenyl Or methyl propyl ketone) decylamine, hydrazine, hydrazine-dimethylaminoethyl acrylate (or methacrylic acid) decylamine, hydrazine-vinyl-2 - caprolactam and hydrazine-vinyl-2- Pyridone; (iii) an ester group-containing compound selected from the group consisting of acrylic acid (or methacrylic acid) alkyl groups (carbon number 1 to 5), propylene glycol (or methacrylic acid) 2-hydroxyethyl group, acrylic acid ( Or methacrylic acid 73247-960427.DOC - 1 - This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) 8 8 8 8 AB c D 1283267 VI. Patent application scope dimethylaminoalkane Base (carbon number 1 to 5) and vinyl acetate; (iv) selected from the group consisting of ethylene, propylene, oxime, butylene, N-pentene, isoprene, 2 · decyl-1 Butene, Ν-hexene, 2-methyl-1-pentene, 3-methyl-1-pentene, 4-methyl-1-pentene, 2-ethyl-1-butanthene, styrene , vinyl toluene, α-methylstyrene, allylamine, ν, Ν-diallylamine, Ν 5 Ν -diallyl-fluorenyl-alkyl (carbon number 1 to 5) amine, ring Compounds of oxyethane, propylene oxide, 2-vinylpyridine and 4-vinylpyridine And (ν) vaporized sulfur, (b) 0 · 〇〇1~3 〇 1% of a suitable compound having a molecular weight of 1,000 or less and having a grade 4 ammonium group; and (c) 0·0 1 to 5% by weight of the surfactant; and (cA) anionic surfactant as the surfactant, (c A) / (b) is not more than 1.0 by weight. 2. According to the scope of the patent application A sterilizing antifouling detergent for a hard surface, wherein (b) is at least one bactericidal compound R1 - (X - R2) R3 IR · Ό (1) selected from the compounds represented by the following formulas (1) to (3) -2 73247-960427.DOC This paper size applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) !283267 ABCD Rb-N Υ· (2) R、/R9'〆 R10 Y· (3) 中,Ri及R6分別為碳數6〜18之烷基或烷婦基,R3及 R刀別為碳數1〜3之烷基或羥烷基,X為芳香環或選自 =00…-CONH-、-0C0·、_NHCCU之酯基或醯胺基, R係當X為酯基或醯胺基時為亦可被羥基所取代之碳數 1〜6的晞烴基,當X為芳香環時,亦可被羥基取代之^ '6 、ΙνΤί 甘 士 / τη 1 1、 . .. 埽 1〜6的晞烴基或_(0_Rll)k·,此處,RI1為乙缔基或丙 基,k為平均卜10的數目,RS為碳數丨㈠的埽烴基, R〜R1G係此等之中1個以上為碳數8~ i 8的烷基,其餘 碳數I〜3之烷基或羥烷基,又,111為〇或1之數目,、造二 步Y ·為陰離子。] 3·,據中請專利範圍第Η之硬質表面用殺菌防污清潔劑, 二中具有⑷之4級按基的單體單元乃來自下述式⑷的化 合物 R12R13C 二 C(FH )—Χ\ 广 Υ· /Ν\ # R17 73247-960427.DOC . 3 本紙張尺度適用中國國家標準(CNS) Α4規格(210X 297公釐) (4) ABCD 1283267 六、申請專利範圍 [式中,R 、R 、R】4分別為氫原子、經基或碳數㈠ 的烷基;X係選自碳數1〜12之烯烴基、_c〇〇Rl8_、 -CONHR18-、-OCORi、、-Ri、〇c〇Rl8·;此處, R18、R19分別為碳數1〜5的烯烴基;為碳數丨〜3的烷 基或羥烷基或R12R13C = C(Ri4)-X- ; Ri6為碳數 fe基、喪基、表甲基;R 17為亦可被經基、幾基、續酸 基、硫S旨基所取代的碳數1〜1 〇的燒基、或、笨甲其, R 17為烷基、羥烷基、或苯甲基時,γ·為陰離子。] 4.根據申請專利範圍第1項之硬質表面用殺菌防污凊潔劑, 其中具有(a)之3級胺基的單體單元乃源自下述式(5)所示 之化合物 15 (5) R12R13C=C( R14 )—X—N 、R16 [式中,R12、R 同]0 R M,R 15及R以係與前述記載 相 4- 73247-960427.DOC 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)Υ· (2) R, /R9'〆R10 Y· (3), Ri and R6 are each an alkyl group or alkane group having a carbon number of 6 to 18, and R3 and R are an alkane having a carbon number of 1 to 3 Or a hydroxyalkyl group, X is an aromatic ring or an ester group or a guanamine group selected from =00...-CONH-, -0C0, _NHCCU, and R is also a hydroxyl group when X is an ester group or a guanamine group. The substituted anthracene hydrocarbon group having 1 to 6 carbon atoms, when X is an aromatic ring, may also be substituted with a hydroxyl group of ^6, ΙνΤί 甘士/τη 1 1 , . . . 埽1~6 anthracene hydrocarbon group or _( 0_Rll)k·, where RI1 is an ethyl group or a propyl group, k is an average number of 10, RS is an anthracene hydrocarbon group having a carbon number of 丨(1), and 1 or more of R to R1G is a carbon number of 8 The alkyl group of ~8, the remaining alkyl group having 1 to 3 carbon atoms or the hydroxyalkyl group, and 111 is the number of ruthenium or 1, and the second step Y is an anion. 3·, according to the patent scope of the third paragraph of the hard surface sterilizing antifouling cleaner, the second unit with (4) 4 grade base unit is from the following formula (4) compound R12R13C two C (FH) - Χ \广Υ· /Ν\ # R17 73247-960427.DOC . 3 This paper scale applies to China National Standard (CNS) Α4 specification (210X 297 mm) (4) ABCD 1283267 VI. Patent application scope [in the formula, R, R, R 4 are each a hydrogen atom, a trans group or an alkyl group having a carbon number (I); X is selected from an alkenyl group having 1 to 12 carbon atoms, _c〇〇Rl8_, -CONHR18-, -OCORi, -Ri, 〇 C〇Rl8·; Here, R18 and R19 are each an alkene group having a carbon number of 1 to 5; an alkyl group or a hydroxyalkyl group having a carbon number of 丨~3 or R12R13C=C(Ri4)-X-; Fe group, sulfhydryl group, epiformyl group; R 17 is a carbon group of 1 to 1 fluorene which may be substituted by a group, a group, a group of a repeating acid group, or a sulfur group, or a When 17 is an alkyl group, a hydroxyalkyl group, or a benzyl group, γ· is an anion. 4. The sterilizing and antifouling agent for a hard surface according to the first aspect of the invention, wherein the monomer unit having the amine group of the (a) ternary group is derived from the compound 15 represented by the following formula (5) ( 5) R12R13C=C( R14 )—X—N , R16 [wherein R12, R are the same as] 0 RM, R 15 and R are related to the above-mentioned description 4- 73247-960427.DOC This paper scale applies to Chinese national standards. (CNS) A4 size (210 X 297 mm)
TW90120399A 2000-08-23 2001-08-20 Bactericidal antifouling detergent for hard surface TWI283267B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000252284A JP2002060786A (en) 2000-08-23 2000-08-23 Germicidal stainproofing agent for hard surface

Publications (1)

Publication Number Publication Date
TWI283267B true TWI283267B (en) 2007-07-01

Family

ID=18741548

Family Applications (1)

Application Number Title Priority Date Filing Date
TW90120399A TWI283267B (en) 2000-08-23 2001-08-20 Bactericidal antifouling detergent for hard surface

Country Status (3)

Country Link
JP (1) JP2002060786A (en)
TW (1) TWI283267B (en)
WO (1) WO2002016536A1 (en)

Families Citing this family (292)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4230153B2 (en) 2002-02-22 2009-02-25 花王株式会社 Antifouling cleaner for hard surfaces
AU2003208609A1 (en) 2002-02-22 2003-09-09 Kao Corporation Antifouling detergent for hard surfaces
JP3980447B2 (en) * 2002-08-14 2007-09-26 花王株式会社 Hard surface cleaning composition
JP2004155803A (en) * 2002-11-01 2004-06-03 Kao Corp Solid cleaning agent composition for flush toilet
JP4130387B2 (en) * 2003-07-11 2008-08-06 花王株式会社 Toilet cleaner
JP4271524B2 (en) * 2003-07-11 2009-06-03 花王株式会社 Aqueous liquid composition
US20120196370A1 (en) 2010-12-03 2012-08-02 Fyodor Urnov Methods and compositions for targeted genomic deletion
WO2005014791A2 (en) 2003-08-08 2005-02-17 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
JP2005232241A (en) * 2004-02-18 2005-09-02 Toyo Aluminium Foil Products Kk Coating agent for removing greasy dirt
US20080131962A1 (en) 2006-05-25 2008-06-05 Sangamo Biosciences, Inc. Engineered cleavage half-domains
AU2005287278B2 (en) 2004-09-16 2011-08-04 Sangamo Biosciences, Inc. Compositions and methods for protein production
EP1913149A4 (en) 2005-07-26 2009-08-05 Sangamo Biosciences Inc Targeted integration and expression of exogenous nucleic acid sequences
WO2007139982A2 (en) * 2006-05-25 2007-12-06 Sangamo Biosciences, Inc. Methods and compositions for gene inactivation
ES2532002T3 (en) 2006-08-11 2015-03-23 Dow Agrosciences Llc Homologous nuclease-mediated recombination with zinc fingers
JP5342126B2 (en) 2006-10-31 2013-11-13 花王株式会社 Bleach composition
AU2007319881B2 (en) 2006-11-13 2012-05-17 Sangamo Therapeutics, Inc. Zinc finger nuclease for targeting the human glucocorticoid receptor locus
MX2009006303A (en) 2006-12-14 2009-10-21 Dow Agrosciences Llc Optimized non-canonical zinc finger proteins.
JP5252826B2 (en) * 2007-04-17 2013-07-31 ディバーシー株式会社 Cleaning composition for hard surface
US8110379B2 (en) 2007-04-26 2012-02-07 Sangamo Biosciences, Inc. Targeted integration into the PPP1R12C locus
CA2692453C (en) 2007-07-12 2018-01-09 Trevor Collingwood Methods and compositions for inactivating alpha 1,6 fucosyltransferase (fut8) gene expression
DK2205749T3 (en) 2007-09-27 2016-08-22 Dow Agrosciences Llc MODIFIED PROTEINS zinc finger, which target the 5-enolpyruvylshikimate-3-phosphate synthase genes
US8563314B2 (en) 2007-09-27 2013-10-22 Sangamo Biosciences, Inc. Methods and compositions for modulating PD1
US11235026B2 (en) 2007-09-27 2022-02-01 Sangamo Therapeutics, Inc. Methods and compositions for modulating PD1
JP5763341B2 (en) 2007-09-27 2015-08-12 サンガモ バイオサイエンシーズ, インコーポレイテッド Rapid in vivo identification of biologically active nucleases
WO2009054985A1 (en) 2007-10-25 2009-04-30 Sangamo Biosciences, Inc. Methods and compositions for targeted integration
CA2720903C (en) 2008-04-14 2019-01-15 Sangamo Biosciences, Inc. Linear donor constructs for targeted integration
DK2268129T3 (en) 2008-04-21 2015-09-28 Danziger Innovations Ltd PLANTEVIRUSEKSPRESSIONSVEKTORER AND USE THEREOF FOR GENERATING GENOTYPEVARIATIONER into plant genomes
US9394531B2 (en) 2008-05-28 2016-07-19 Sangamo Biosciences, Inc. Compositions for linking DNA-binding domains and cleavage domains
KR101802393B1 (en) 2008-06-10 2017-11-28 상가모 테라퓨틱스, 인코포레이티드 Methods and compositions for generation of bax- and bak-deficient cell lines
CA2734235C (en) 2008-08-22 2019-03-26 Sangamo Biosciences, Inc. Methods and compositions for targeted single-stranded cleavage and targeted integration
WO2010053518A2 (en) 2008-10-29 2010-05-14 Sangamo Biosciences, Inc. Methods and compositions for inactivating glutamine synthetase gene expression
AU2009322964B2 (en) 2008-12-04 2014-10-09 Sangamo Therapeutics, Inc. Genome editing in rats using zinc-finger nucleases
CN102333868B (en) 2008-12-17 2015-01-07 陶氏益农公司 Targeted integration into the zp15 locus
JP5281420B2 (en) * 2009-01-20 2013-09-04 花王株式会社 Liquid detergent composition for hard surfaces
AU2010211057B2 (en) 2009-02-04 2014-12-18 Sangamo Therapeutics, Inc. Methods and compositions for treating neuropathies
JP5932632B2 (en) 2009-03-20 2016-06-15 サンガモ バイオサイエンシーズ, インコーポレイテッド Modification of CXCR4 using modified zinc finger protein
CA2756833C (en) 2009-04-09 2019-11-19 Sangamo Biosciences, Inc. Targeted integration into stem cells
US8772008B2 (en) 2009-05-18 2014-07-08 Sangamo Biosciences, Inc. Methods and compositions for increasing nuclease activity
EP2449135B1 (en) 2009-06-30 2016-01-06 Sangamo BioSciences, Inc. Rapid screening of biologically active nucleases and isolation of nuclease-modified cells
EP2461819A4 (en) 2009-07-28 2013-07-31 Sangamo Biosciences Inc Methods and compositions for treating trinucleotide repeat disorders
KR102262704B1 (en) 2009-08-11 2021-06-09 상가모 테라퓨틱스, 인코포레이티드 Organisms homozygous for targeted modification
US9476060B2 (en) 2009-10-21 2016-10-25 Danziger Innovations Ltd. Generating genotypic variations in plant genomes by gamete infection
ES2646138T3 (en) 2009-10-22 2017-12-12 Sangamo Biosciences, Inc. Genetically manipulated zinc finger proteins targeting plant genes involved in fatty acid biosynthesis
US8956828B2 (en) 2009-11-10 2015-02-17 Sangamo Biosciences, Inc. Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
CN102812034B (en) 2010-01-22 2016-08-03 陶氏益农公司 Target gene group is transformed
ES2751916T3 (en) 2010-02-08 2020-04-02 Sangamo Therapeutics Inc Genomanipulated half-cleavages
JP2013518602A (en) 2010-02-09 2013-05-23 サンガモ バイオサイエンシーズ, インコーポレイテッド Targeted genome modification by partially single-stranded donor molecules
JP5952263B2 (en) 2010-04-26 2016-07-13 サンガモ バイオサイエンシーズ, インコーポレイテッド Genome editing of the ROSA locus using zinc finger nuclease
EP3636766A1 (en) 2010-05-03 2020-04-15 Sangamo Therapeutics, Inc. Compositions for linking zinc finger modules
JP5642429B2 (en) * 2010-05-31 2014-12-17 上野製薬株式会社 Cleaning disinfectant composition
CA2805442C (en) 2010-07-21 2020-05-12 Sangamo Biosciences, Inc. Methods and compositions for modification of an hla locus
EP2622090B1 (en) 2010-09-27 2019-06-19 Sangamo Therapeutics, Inc. Compositions for inhibiting viral entry into cells
JP5769570B2 (en) * 2010-09-28 2015-08-26 小林製薬株式会社 Biofilm remover, biofilm removal composition, and biofilm removal method
US9175280B2 (en) 2010-10-12 2015-11-03 Sangamo Biosciences, Inc. Methods and compositions for treating hemophilia B
JP5705510B2 (en) * 2010-11-25 2015-04-22 大日本除蟲菊株式会社 Acidic antibacterial detergent composition
GB201022132D0 (en) * 2010-12-31 2011-02-02 Byotrol Plc Anti-microbial composition
US9267123B2 (en) 2011-01-05 2016-02-23 Sangamo Biosciences, Inc. Methods and compositions for gene correction
JP6000514B2 (en) * 2011-03-17 2016-09-28 株式会社Adeka Oil stain cleaning composition
JP5659087B2 (en) * 2011-06-08 2015-01-28 花王株式会社 Liquid detergent composition for hard surfaces
JP5832189B2 (en) * 2011-07-25 2015-12-16 大日本除蟲菊株式会社 Rinsing accelerator for hard surface cleaner
US9161995B2 (en) 2011-07-25 2015-10-20 Sangamo Biosciences, Inc. Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (CFTR) gene
CA2848417C (en) 2011-09-21 2023-05-02 Sangamo Biosciences, Inc. Methods and compositions for regulation of transgene expression
US8895264B2 (en) 2011-10-27 2014-11-25 Sangamo Biosciences, Inc. Methods and compositions for modification of the HPRT locus
US9458205B2 (en) 2011-11-16 2016-10-04 Sangamo Biosciences, Inc. Modified DNA-binding proteins and uses thereof
GB2501341B (en) * 2011-12-29 2014-10-22 Byotrol Plc Anti-microbial composition
WO2013130824A1 (en) 2012-02-29 2013-09-06 Sangamo Biosciences, Inc. Methods and compositions for treating huntington's disease
ES2828663T3 (en) 2012-04-18 2021-05-27 Univ Leland Stanford Junior Nondisruptive Genetic Direction
KR102091298B1 (en) 2012-05-02 2020-03-19 다우 아그로사이언시즈 엘엘씨 Targeted modification of malate dehydrogenase
EP2847338B1 (en) 2012-05-07 2018-09-19 Sangamo Therapeutics, Inc. Methods and compositions for nuclease-mediated targeted integration of transgenes
JP6052957B2 (en) * 2012-07-03 2016-12-27 花王株式会社 Liquid fragrance composition for flush toilet
ES2613691T3 (en) 2012-07-11 2017-05-25 Sangamo Biosciences, Inc. Methods and compositions for the treatment of lysosomal storage diseases
US10648001B2 (en) 2012-07-11 2020-05-12 Sangamo Therapeutics, Inc. Method of treating mucopolysaccharidosis type I or II
JP6329537B2 (en) 2012-07-11 2018-05-23 サンガモ セラピューティクス, インコーポレイテッド Methods and compositions for delivery of biological agents
EA039384B1 (en) 2012-08-29 2022-01-20 Сангамо Байосаенсез, Инк. Zinc finger protein for modulating expression of bcl11a gene and method of modulating expression of globin gene
UA118090C2 (en) 2012-09-07 2018-11-26 ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі Fad2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks
UA119135C2 (en) 2012-09-07 2019-05-10 ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі Engineered transgene integration platform (etip) for gene targeting and trait stacking
RU2665811C2 (en) 2012-09-07 2018-09-04 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Fad3 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks
HUE050797T2 (en) 2012-10-10 2021-01-28 Sangamo Therapeutics Inc T cell modifying compounds and uses thereof
US9255250B2 (en) 2012-12-05 2016-02-09 Sangamo Bioscience, Inc. Isolated mouse or human cell having an exogenous transgene in an endogenous albumin gene
AU2013359091A1 (en) 2012-12-13 2015-07-02 Dow Agrosciences Llc Precision gene targeting to a particular locus in maize
AU2014218621B2 (en) 2013-02-25 2019-11-07 Sangamo Therapeutics, Inc. Methods and compositions for enhancing nuclease-mediated gene disruption
CN105208866B (en) 2013-03-21 2018-11-23 桑格摩生物治疗股份有限公司 Use engineering zinc finger protein nuclease targeted disruption T cell receptor gene
KR102192599B1 (en) 2013-04-05 2020-12-18 다우 아그로사이언시즈 엘엘씨 Methods and compositions for integration of an exogenous sequence within the genome of plants
US9873894B2 (en) 2013-05-15 2018-01-23 Sangamo Therapeutics, Inc. Methods and compositions for treatment of a genetic condition
JP6588438B2 (en) 2013-08-28 2019-10-09 サンガモ セラピューティクス, インコーポレイテッド Composition for linking a DNA binding domain and a cleavage domain
US10117899B2 (en) 2013-10-17 2018-11-06 Sangamo Therapeutics, Inc. Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells
CN116836957A (en) 2013-10-17 2023-10-03 桑格摩生物科学股份有限公司 Delivery methods and compositions for nuclease-mediated genome engineering
NZ746567A (en) 2013-11-04 2019-09-27 Dow Agrosciences Llc Optimal soybean loci
JP6633532B2 (en) 2013-11-04 2020-01-22 ダウ アグロサイエンシィズ エルエルシー Optimal corn loci
CA2926822C (en) 2013-11-04 2022-12-13 Dow Agrosciences Llc Optimal soybean loci
NZ719494A (en) 2013-11-04 2017-09-29 Dow Agrosciences Llc Optimal maize loci
AU2014346424B2 (en) 2013-11-11 2020-09-17 Sangamo Therapeutics, Inc. Methods and compositions for treating Huntington's Disease
EP3068881B1 (en) 2013-11-13 2019-02-27 Children's Medical Center Corporation Nuclease-mediated regulation of gene expression
US9932607B2 (en) 2013-11-15 2018-04-03 The Board Of Trustees Of The Leland Stanford Junior University Site-specific integration of transgenes into human cells
ES2813367T3 (en) 2013-12-09 2021-03-23 Sangamo Therapeutics Inc Methods and compositions for genomic engineering
JP5752220B2 (en) * 2013-12-16 2015-07-22 花王株式会社 Bactericidal detergent composition for hard surfaces
RS60514B1 (en) 2014-02-03 2020-08-31 Sangamo Therapeutics Inc Methods and compositions for treatment of a beta thalessemia
JP6606088B2 (en) 2014-02-24 2019-11-13 サンガモ セラピューティクス, インコーポレイテッド Methods and compositions for nuclease-mediated targeted integration
TW201538518A (en) 2014-02-28 2015-10-16 Dow Agrosciences Llc Root specific expression conferred by chimeric gene regulatory elements
WO2015143046A2 (en) 2014-03-18 2015-09-24 Sangamo Biosciences, Inc. Methods and compositions for regulation of zinc finger protein expression
KR20220100728A (en) 2014-03-21 2022-07-15 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 Genome editing without nucleases
US10507232B2 (en) 2014-04-02 2019-12-17 University Of Florida Research Foundation, Incorporated Materials and methods for the treatment of latent viral infection
BR112016025849A2 (en) 2014-05-08 2017-10-17 Chdi Foundation Inc methods and compositions for the treatment of huntington's disease
CA2947622A1 (en) 2014-05-13 2015-11-19 Sangamo Biosciences, Inc. Genome editing methods and compositions for prevention or treatment of a disease
EP3152319A4 (en) 2014-06-05 2017-12-27 Sangamo BioSciences, Inc. Methods and compositions for nuclease design
CA2954201A1 (en) 2014-07-08 2016-01-14 Vib Vzw Means and methods to increase plant yield
DK3169778T3 (en) 2014-07-14 2023-12-18 Univ Washington State NANOS KNOCKOUT THAT ELIMINATES GERM CELLS
CN107075483A (en) 2014-07-15 2017-08-18 朱诺治疗学股份有限公司 The engineered cell treated for adoptive cellular
US11278572B2 (en) 2014-07-18 2022-03-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Reducing CXCR4 expression and/or function to enhance engraftment of hematopoietic stem cells
WO2016014837A1 (en) 2014-07-25 2016-01-28 Sangamo Biosciences, Inc. Gene editing for hiv gene therapy
US9816074B2 (en) 2014-07-25 2017-11-14 Sangamo Therapeutics, Inc. Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells
US9616090B2 (en) 2014-07-30 2017-04-11 Sangamo Biosciences, Inc. Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
PT3194570T (en) 2014-09-16 2021-08-06 Sangamo Therapeutics Inc Methods and compositions for nuclease-mediated genome engineering and correction in hematopoietic stem cells
US10889834B2 (en) 2014-12-15 2021-01-12 Sangamo Therapeutics, Inc. Methods and compositions for enhancing targeted transgene integration
JP6516353B2 (en) * 2014-12-26 2019-05-22 ライオン株式会社 Liquid cleaning agent for bathroom
US20180002379A1 (en) 2015-01-21 2018-01-04 Sangamo Therapeutics, Inc. Methods and compositions for identification of highly specific nucleases
CA2974381A1 (en) 2015-01-26 2016-08-04 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
US10676726B2 (en) 2015-02-09 2020-06-09 Duke University Compositions and methods for epigenome editing
EP3277823B1 (en) 2015-04-03 2023-09-13 Dana-Farber Cancer Institute, Inc. Composition and methods of genome editing of b-cells
RU2017137599A (en) 2015-04-15 2019-05-15 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи VEGETABLE PROMOTER FOR THE TRANSGEN EXPRESSION
EP3283632A1 (en) 2015-04-15 2018-02-21 Dow Agrosciences LLC Plant promoter for transgene expression
EP3292219B9 (en) 2015-05-04 2022-05-18 Ramot at Tel-Aviv University Ltd. Methods and kits for fragmenting dna
US10179918B2 (en) 2015-05-07 2019-01-15 Sangamo Therapeutics, Inc. Methods and compositions for increasing transgene activity
AU2016261927B2 (en) 2015-05-12 2022-04-07 Sangamo Therapeutics, Inc. Nuclease-mediated regulation of gene expression
CN108174607A (en) 2015-05-29 2018-06-15 朱诺治疗学股份有限公司 For adjusting the composition and method of inhibition interaction in genetically engineered cell
US9957501B2 (en) 2015-06-18 2018-05-01 Sangamo Therapeutics, Inc. Nuclease-mediated regulation of gene expression
AU2016291778B2 (en) 2015-07-13 2021-05-06 Sangamo Therapeutics, Inc. Delivery methods and compositions for nuclease-mediated genome engineering
MA42895A (en) 2015-07-15 2018-05-23 Juno Therapeutics Inc MODIFIED CELLS FOR ADOPTIVE CELL THERAPY
RU2018107842A (en) 2015-08-06 2019-09-09 Дзе Кьюрейторз Оф Дзе Юниверсити Оф Миссури PATHOGEN-RESISTANT ANIMALS WITH MODIFIED CD163 GENES
TW201718861A (en) 2015-09-22 2017-06-01 道禮責任有限公司 Plant promoter and 3'UTR for transgene expression
TW201718862A (en) 2015-09-22 2017-06-01 Dow Agrosciences Llc Plant promoter and 3' UTR for transgene expression
BR112018005779A2 (en) 2015-09-23 2018-10-09 Sangamo Therapeutics, Inc. htt repressors and uses thereof
AU2016340893B2 (en) 2015-10-22 2019-06-27 Corteva Agriscience Llc Plant promoter for transgene expression
PT3371314T (en) 2015-11-04 2023-08-31 Fate Therapeutics Inc Genomic engineering of pluripotent cells
SG11201803145RA (en) 2015-11-04 2018-05-30 Fate Therapeutics Inc Methods and compositions for inducing hematopoietic cell differentiation
WO2017078935A1 (en) 2015-11-04 2017-05-11 Dow Agrosciences Llc Plant promoter for transgene expression
AU2016361350B2 (en) 2015-11-23 2023-04-06 Sangamo Therapeutics, Inc. Methods and compositions for engineering immunity
KR20180088911A (en) 2015-12-18 2018-08-07 상가모 테라퓨틱스, 인코포레이티드 Targeted Collapse of MHC Cell Receptors
JP7128741B2 (en) 2015-12-18 2022-08-31 サンガモ セラピューティクス, インコーポレイテッド Targeted disruption of T-cell receptors
ES2895430T3 (en) 2016-01-15 2022-02-21 Univ Minnesota Methods and compositions for the treatment of neurological disease
US10724020B2 (en) 2016-02-02 2020-07-28 Sangamo Therapeutics, Inc. Compositions for linking DNA-binding domains and cleavage domains
AU2017238512B2 (en) 2016-03-23 2022-12-08 Dana-Farber Cancer Institute, Inc. Methods for enhancing the efficiency of gene editing
MA45491A (en) 2016-06-27 2019-05-01 Juno Therapeutics Inc CMH-E RESTRICTED EPITOPES, BINDING MOLECULES AND RELATED METHODS AND USES
EP3475446A1 (en) 2016-06-27 2019-05-01 Juno Therapeutics, Inc. Method of identifying peptide epitopes, molecules that bind such epitopes and related uses
ES2938210T3 (en) 2016-07-13 2023-04-05 Vertex Pharma Methods, compositions and kits to increase the efficiency of genome editing
MA53246A (en) 2016-07-27 2021-07-28 Univ Case Western Reserve COMPOUNDS AND METHODS FOR PROMOTING MYELINATION
US11193136B2 (en) 2016-08-09 2021-12-07 Vib Vzw Cellulose synthase inhibitors and mutant plants
BR112019003327A2 (en) 2016-08-24 2019-07-02 Sangamo Therapeutics Inc specific target engineered nucleases
BR112019003100A2 (en) 2016-08-24 2019-07-09 Sangamo Therapeutics Inc regulation of gene expression using engineered nucleases
CA3035534A1 (en) 2016-09-07 2018-03-15 Sangamo Therapeutics, Inc. Modulation of liver genes
US10400246B2 (en) 2016-10-03 2019-09-03 Dow Agrosciences Llc Plant promoter for transgene expression
CA3037086A1 (en) 2016-10-03 2018-04-12 Juno Therapeutics, Inc. Hpv-specific binding molecules
EP3518657B1 (en) 2016-10-03 2022-07-13 Corteva Agriscience LLC Plant promoter for transgene expression
EP3523422A1 (en) 2016-10-05 2019-08-14 FUJIFILM Cellular Dynamics, Inc. Generating mature lineages from induced pluripotent stem cells with mecp2 disruption
CN110381963A (en) 2016-10-13 2019-10-25 朱诺治疗学股份有限公司 It is related to the immunotherapy method and composition of tryptophan metabolic pathway regulator
EP3528852A4 (en) 2016-10-20 2020-06-03 Sangamo Therapeutics, Inc. Methods and compositions for the treatment of fabry disease
AU2017347928A1 (en) 2016-10-31 2019-05-09 Sangamo Therapeutics, Inc. Gene correction of scid-related genes in hematopoietic stem and progenitor cells
AU2017367722B2 (en) 2016-12-01 2024-02-01 Sangamo Therapeutics, Inc. Tau modulators and methods and compositions for delivery thereof
CA3045323A1 (en) 2016-12-02 2018-06-07 Juno Therapeutics, Inc. Engineered b cells and related compositions and methods
KR20190098747A (en) 2016-12-05 2019-08-22 주노 쎄러퓨티크스 인코퍼레이티드 Method of manufacturing engineered cells for adoptive cell therapy
EP4276187A3 (en) 2016-12-08 2024-01-17 Case Western Reserve University Methods and compositions for enhancing functional myelin production
US11920148B2 (en) 2017-02-22 2024-03-05 Crispr Therapeutics Ag Compositions and methods for gene editing
BR112019021993A2 (en) 2017-04-20 2020-05-12 Oregon Health & Science University HUMAN GENE CORRECTION
JP2020518245A (en) 2017-05-03 2020-06-25 サンガモ セラピューティクス, インコーポレイテッド Methods and compositions for modification of the cystic fibrosis transmembrane conductance regulator (CFTR) gene
US11512287B2 (en) 2017-06-16 2022-11-29 Sangamo Therapeutics, Inc. Targeted disruption of T cell and/or HLA receptors
SG11202002728VA (en) 2017-10-03 2020-04-29 Juno Therapeutics Inc Hpv-specific binding molecules
WO2019089982A1 (en) 2017-11-01 2019-05-09 Juno Therapeutics, Inc. Method of assessing activity of recombinant antigen receptors
WO2019094725A2 (en) 2017-11-09 2019-05-16 Sangamo Therapeutics, Inc. Genetic modification of cytokine inducible sh2-containing protein (cish) gene
AU2018388413A1 (en) 2017-12-22 2020-06-11 Fate Therapeutics, Inc. Enhanced immune effector cells and use thereof
CN111757876B (en) 2018-01-17 2024-03-22 沃泰克斯药物股份有限公司 DNA-PK inhibitors
MA51616A (en) 2018-01-17 2020-11-25 Vertex Pharma DNA-PK INHIBITORS
WO2019143677A1 (en) 2018-01-17 2019-07-25 Vertex Pharmaceuticals Incorporated Quinoxalinone compounds, compositions, methods, and kits for increasing genome editing efficiency
US11401512B2 (en) 2018-02-08 2022-08-02 Sangamo Therapeutics, Inc. Engineered target specific nucleases
JP7075655B2 (en) * 2018-03-14 2022-05-26 株式会社ニイタカ Detergent composition, spray bottle, wet wiper and deodorant disinfectant cleaning method
CN111954715A (en) 2018-03-29 2020-11-17 菲特治疗公司 Engineered immune effector cells and uses thereof
MX2020010461A (en) 2018-04-05 2021-01-15 Juno Therapeutics Inc T cells expressing a recombinant receptor, related polynucleotides and methods.
KR20210029707A (en) 2018-04-05 2021-03-16 주노 쎄러퓨티크스 인코퍼레이티드 Method for producing cells expressing recombinant receptors and related compositions
CN112566698A (en) 2018-04-05 2021-03-26 朱诺治疗学股份有限公司 T cell receptor and engineered cells expressing the same
EP3772947A4 (en) 2018-04-09 2021-12-01 Rhodia Operations Compositions and methods for long lasting disinfection
CN112313246A (en) 2018-04-18 2021-02-02 桑格摩生物治疗股份有限公司 Zinc finger protein compositions for modulating Huntingtin (HTT)
KR20210008502A (en) 2018-05-11 2021-01-22 크리스퍼 테라퓨틱스 아게 Methods and compositions for treating cancer
US11690921B2 (en) 2018-05-18 2023-07-04 Sangamo Therapeutics, Inc. Delivery of target specific nucleases
GB201809273D0 (en) 2018-06-06 2018-07-25 Vib Vzw Novel mutant plant cinnamoyl-coa reductase proteins
EP3802839A1 (en) 2018-06-07 2021-04-14 The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) Nucleic acid constructs and methods of using same
EP3800998A1 (en) 2018-06-07 2021-04-14 The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) Methods of regenerating and transforming cannabis
CN112867792A (en) 2018-08-23 2021-05-28 桑格摩生物治疗股份有限公司 Engineered target-specific base editor
JP2020041074A (en) * 2018-09-12 2020-03-19 ライオン株式会社 Liquid detergent composition for clothing
AU2019344927A1 (en) 2018-09-18 2021-04-01 Sangamo Therapeutics, Inc. Programmed cell death 1 (PD1) specific nucleases
SG11202104523PA (en) 2018-11-07 2021-05-28 Crispr Therapeutics Ag Anti-liv1 immune cell cancer therapy
AU2019377892A1 (en) 2018-11-07 2021-05-13 Crispr Therapeutics Ag Anti-CD33 immune cell cancer therapy
BR112021008083A2 (en) 2018-11-07 2021-08-10 Crispr Therapeutics Ag anti-ptk7 immune cell cancer therapy
AU2019391114A1 (en) 2018-12-05 2021-06-24 Vertex Pharmaceuticals Incorporated Gene-editing systems for editing a cystic fibrosis transmembrane regulator (CFTR) gene
GB201820109D0 (en) 2018-12-11 2019-01-23 Vib Vzw Plants with a lignin trait and udp-glycosyltransferase mutation
JP7335068B2 (en) * 2018-12-20 2023-08-29 中国塗料株式会社 Antifouling paint composition, antifouling coating film, substrate with antifouling coating film, antifouling method for substrate, and method for producing substrate with antifouling coating film
US11453639B2 (en) 2019-01-11 2022-09-27 Acuitas Therapeutics, Inc. Lipids for lipid nanoparticle delivery of active agents
WO2020162978A1 (en) 2019-02-06 2020-08-13 Sangamo Therapeutics, Inc. Method for the treatment of mucopolysaccharidosis type i
AU2020236937B2 (en) 2019-03-08 2023-06-15 Obsidian Therapeutics, Inc. CD40L compositions and methods for tunable regulation
JP6700453B1 (en) * 2019-03-22 2020-05-27 株式会社Adeka Hard surface cleaner composition and hard surface cleaning method
MA55531A (en) 2019-04-02 2022-02-09 Sangamo Therapeutics Inc METHODS FOR THE TREATMENT OF BETA-THALASSEMIA
JP2022529500A (en) 2019-04-23 2022-06-22 サンガモ セラピューティクス, インコーポレイテッド Chromosome 9 open reading frame 72 gene expression modulator and its use
MX2021013219A (en) 2019-05-01 2022-02-17 Juno Therapeutics Inc Cells expressing a recombinant receptor from a modified tgfbr2 locus, related polynucleotides and methods.
AU2020265749A1 (en) 2019-05-01 2022-01-06 Juno Therapeutics, Inc. Cells expressing a chimeric receptor from a modified CD247 locus, related polynucleotides and methods
AU2020307667A1 (en) 2019-06-27 2022-01-20 Crispr Therapeutics Ag Use of chimeric antigen receptor T cells and NK cell inhibitors for treating cancer
EP4007596A1 (en) 2019-08-01 2022-06-08 Sana Biotechnology, Inc. Dux4 expressing cells and uses thereof
JP2022546317A (en) 2019-08-23 2022-11-04 サナ バイオテクノロジー,インコーポレイテッド CD24-expressing cells and their uses
CN114729325A (en) 2019-09-06 2022-07-08 克里斯珀医疗股份公司 Genetically engineered T cells with improved persistence in culture
US20230002459A1 (en) 2019-10-02 2023-01-05 Sangamo Therapeutics, Inc. Zinc Finger Protein Transcription Factors for Treatment of Prion Disease
EP4041754A1 (en) 2019-10-02 2022-08-17 Sangamo Therapeutics, Inc. Zinc finger protein transcription factors for repressing alpha-synuclein expression
US20230048224A1 (en) 2019-11-01 2023-02-16 Sangamo Therapeutics, Inc. Zinc finger nuclease variants for treating or preventing lysosomal storage diseases
TW202132565A (en) 2019-11-01 2021-09-01 美商聖加莫治療股份有限公司 Gin recombinase variants
US20230056856A1 (en) 2020-01-08 2023-02-23 Obsidian Therapeutics, Inc. Compositions and methods for tunable regulation of transcription
AR121118A1 (en) 2020-01-22 2022-04-20 Sangamo Therapeutics Inc ZINC FINGER PROTEIN TRANSCRIPTION FACTORS TO REPRESS TAU EXPRESSION
EP4097124A1 (en) 2020-01-28 2022-12-07 The Broad Institute Inc. Base editors, compositions, and methods for modifying the mitochondrial genome
KR20220158046A (en) 2020-03-25 2022-11-29 사나 바이오테크놀로지, 인크. Immunocompromised Neuronal Cells for Treatment of Nervous System Disorders and Conditions
EP4146812A1 (en) 2020-05-06 2023-03-15 Cellectis S.A. Methods for targeted insertion of exogenous sequences in cellular genomes
CA3177621A1 (en) 2020-05-06 2021-11-11 Alexandre Juillerat Methods to genetically modify cells for delivery of therapeutic proteins
WO2021231661A2 (en) 2020-05-13 2021-11-18 Juno Therapeutics, Inc. Process for producing donor-batched cells expressing a recombinant receptor
WO2021236852A1 (en) 2020-05-20 2021-11-25 Sana Biotechnology, Inc. Methods and compositions for treatment of viral infections
WO2021247836A1 (en) 2020-06-03 2021-12-09 Board Of Regents, The University Of Texas System Methods for targeting shp-2 to overcome resistance
CN116234558A (en) 2020-06-26 2023-06-06 朱诺治疗学有限公司 Engineered T cells conditionally expressing recombinant receptors, related polynucleotides and methods
MX2023001831A (en) 2020-08-13 2023-06-29 Sana Biotechnology Inc Methods of treating sensitized patients with hypoimmunogenic cells, and associated methods and compositions.
US20220064596A1 (en) 2020-08-25 2022-03-03 Kite Pharma, Inc. T cells with improved functionality
EP4176048A1 (en) 2020-09-23 2023-05-10 CRISPR Therapeutics AG Genetically engineered t cells with regnase-1 and/or tgfbrii disruption have improved functionality and persistence
US20240043829A1 (en) 2020-09-25 2024-02-08 Sangamo Therapeutics, Inc. Zinc finger fusion proteins for nucleobase editing
CN116917335A (en) 2020-10-02 2023-10-20 桑格摩生物治疗股份有限公司 Novel zinc finger protein transcription factors for repressing expression of alpha-SYNUCLEIN (SYNUCLEIN)
US20230398148A1 (en) 2020-11-04 2023-12-14 Juno Therapeutics, Inc. Cells expressing a chimeric receptor from a modified invariant cd3 immunoglobulin superfamily chain locus and related polynucleotides and methods
CA3200855A1 (en) 2020-11-16 2022-05-19 Pig Improvement Company Uk Limited Influenza a-resistant animals having edited anp32 genes
EP4255922A1 (en) 2020-12-03 2023-10-11 Century Therapeutics, Inc. Genetically engineered cells and uses thereof
US11661459B2 (en) 2020-12-03 2023-05-30 Century Therapeutics, Inc. Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
WO2022137181A1 (en) 2020-12-23 2022-06-30 Crispr Therapeutics Ag Co-use of lenalidomide with car-t cells
AU2021412988A1 (en) 2020-12-31 2023-06-15 Sana Biotechnology, Inc. Methods and compositions for modulating car-t activity
US20220288122A1 (en) 2021-03-09 2022-09-15 Crispr Therapeutics Ag Genetically engineered t cells with ptpn2 knockout have improved functionality and anti-tumor activity
EP4314280A1 (en) 2021-03-22 2024-02-07 Juno Therapeutics, Inc. Method to assess potency of viral vector particles
CN117441010A (en) 2021-04-07 2024-01-23 世纪治疗股份有限公司 Compositions and methods for producing alpha-beta T cells from induced pluripotent stem cells
CA3214045A1 (en) 2021-04-07 2022-10-13 Century Therapeutics, Inc. Compositions and methods for generating gamma-delta t cells from induced pluripotent stem cells
EP4319799A1 (en) 2021-04-07 2024-02-14 Century Therapeutics, Inc. Combined artificial cell death/reporter system polypeptide for chimeric antigen receptor cell and uses thereof
AU2022269643A1 (en) 2021-05-05 2023-11-02 FUJIFILM Cellular Dynamics, Inc. Methods and compositions for ipsc-derived microglia
US20220389436A1 (en) 2021-05-26 2022-12-08 FUJIFILM Cellular Dynamics, Inc. Methods to prevent rapid silencing of genes in pluripotent stem cells
IL308097A (en) 2021-05-27 2023-12-01 Sana Biotechnology Inc Hypoimmunogenic cells comprising engineered hla-e or hla-g
CA3225283A1 (en) 2021-07-14 2023-01-19 Sonja SCHREPFER Altered expression of y chromosome-linked antigens in hypoimmunogenic cells
WO2023010135A1 (en) 2021-07-30 2023-02-02 Tune Therapeutics, Inc. Compositions and methods for modulating expression of methyl-cpg binding protein 2 (mecp2)
WO2023010133A2 (en) 2021-07-30 2023-02-02 Tune Therapeutics, Inc. Compositions and methods for modulating expression of frataxin (fxn)
IL310702A (en) 2021-08-11 2024-04-01 Sana Biotechnology Inc Inducible systems for altering gene expression in hypoimmunogenic cells
AU2022325231A1 (en) 2021-08-11 2024-02-08 Sana Biotechnology, Inc. Genetically modified cells for allogeneic cell therapy to reduce complement-mediated inflammatory reactions
IL310691A (en) 2021-08-11 2024-04-01 Sana Biotechnology Inc Genetically modified primary cells for allogeneic cell therapy
AU2022325955A1 (en) 2021-08-11 2024-02-08 Sana Biotechnology, Inc. Genetically modified cells for allogeneic cell therapy to reduce instant blood mediated inflammatory reactions
WO2023019226A1 (en) 2021-08-11 2023-02-16 Sana Biotechnology, Inc. Genetically modified cells for allogeneic cell therapy
US20230183644A1 (en) 2021-09-10 2023-06-15 FUJIFILM Cellular Dynamics, Inc. Compositions of induced pluripotent stem cell-derived cells and methods of use thereof
WO2023042079A1 (en) 2021-09-14 2023-03-23 Crispr Therapeutics Ag Genetically engineered immune cells having a disrupted cd83 gene
CA3234231A1 (en) 2021-10-21 2023-04-27 Vertex Pharmaceuticals Incorporated Hypoimmune cells
WO2023069790A1 (en) 2021-10-22 2023-04-27 Sana Biotechnology, Inc. Methods of engineering allogeneic t cells with a transgene in a tcr locus and associated compositions and methods
WO2023076880A1 (en) 2021-10-25 2023-05-04 Board Of Regents, The University Of Texas System Foxo1-targeted therapy for the treatment of cancer
AU2022376962A1 (en) 2021-10-29 2024-04-18 FUJIFILM Cellular Dynamics, Inc. Dopaminergic neurons comprising mutations and methods of use thereof
WO2023081900A1 (en) 2021-11-08 2023-05-11 Juno Therapeutics, Inc. Engineered t cells expressing a recombinant t cell receptor (tcr) and related systems and methods
WO2023105244A1 (en) 2021-12-10 2023-06-15 Pig Improvement Company Uk Limited Editing tmprss2/4 for disease resistance in livestock
WO2023111913A1 (en) 2021-12-15 2023-06-22 Crispr Therapeutics Ag Engineered anti-liv1 cell with regnase-1 and/or tgfbrii disruption
WO2023119201A2 (en) 2021-12-22 2023-06-29 Crispr Therapeutics Ag Genetically engineered t cells with disrupted casitas b-lineage lymphoma proto-oncogene-b (cblb) and uses thereof
WO2023122722A1 (en) 2021-12-22 2023-06-29 Sangamo Therapeutics, Inc. Novel zinc finger fusion proteins for nucleobase editing
WO2023122337A1 (en) 2021-12-23 2023-06-29 Sana Biotechnology, Inc. Chimeric antigen receptor (car) t cells for treating autoimmune disease and associated methods
WO2023129937A1 (en) 2021-12-29 2023-07-06 Century Therapeutics, Inc. Genetically engineered cells having anti-cd19 / anti-cd22 chimeric antigen receptors, and uses thereof
WO2023131616A1 (en) 2022-01-05 2023-07-13 Vib Vzw Means and methods to increase abiotic stress tolerance in plants
WO2023131637A1 (en) 2022-01-06 2023-07-13 Vib Vzw Improved silage grasses
WO2023137472A2 (en) 2022-01-14 2023-07-20 Tune Therapeutics, Inc. Compositions, systems, and methods for programming t cell phenotypes through targeted gene repression
WO2023137471A1 (en) 2022-01-14 2023-07-20 Tune Therapeutics, Inc. Compositions, systems, and methods for programming t cell phenotypes through targeted gene activation
WO2023144199A1 (en) 2022-01-26 2023-08-03 Vib Vzw Plants having reduced levels of bitter taste metabolites
WO2023154578A1 (en) 2022-02-14 2023-08-17 Sana Biotechnology, Inc. Methods of treating patients exhibiting a prior failed therapy with hypoimmunogenic cells
WO2023158836A1 (en) 2022-02-17 2023-08-24 Sana Biotechnology, Inc. Engineered cd47 proteins and uses thereof
TW202340457A (en) 2022-02-28 2023-10-16 美商凱特製藥公司 Allogeneic therapeutic cells
US20230279376A1 (en) 2022-03-01 2023-09-07 Crispr Therapeutics Ag Methods and compositions for treating angiopoietin-like 3 (angptl3) related conditions
WO2023173123A1 (en) 2022-03-11 2023-09-14 Sana Biotechnology, Inc. Genetically modified cells and compositions and uses thereof
US20230293646A1 (en) 2022-03-21 2023-09-21 Crispr Therapeutics Ag Methods and compositions for treating lipoprotein-related diseases
WO2023180967A1 (en) 2022-03-23 2023-09-28 Crispr Therapeutics Ag Anti-cd83 car-t cells with regnase-1 and/or tgfbrii disruption
WO2023180968A1 (en) 2022-03-23 2023-09-28 Crispr Therapeutics Ag Anti-cd19 car-t cells with multiple gene edits and therapeutic uses thereof
WO2023230613A1 (en) 2022-05-27 2023-11-30 The Broad Institute, Inc. Improved mitochondrial base editors and methods for editing mitochondrial dna
WO2023240169A1 (en) 2022-06-08 2023-12-14 Century Therapeutics, Inc. Immunoeffector cells derived from induced pluripotent stem cells genetically engineered with membrane bound il12 and uses thereof
WO2023240212A2 (en) 2022-06-08 2023-12-14 Century Therapeutics, Inc. Genetically engineered cells having anti-cd133 / anti-egfr chimeric antigen receptors, and uses thereof
WO2023240147A1 (en) 2022-06-08 2023-12-14 Century Therapeutics, Inc. Genetically engineered cells expressing cd16 variants and nkg2d and uses thereof
US20240041757A1 (en) 2022-06-17 2024-02-08 Crispr Therapeutics Ag LIPID NANOPARTICLES (LNPs)-BASED OCULAR DELIVERY
WO2023248145A1 (en) 2022-06-21 2023-12-28 Crispr Therapeutics Ag Compositions and methods for treating human immunodeficiency virus
WO2023248147A1 (en) 2022-06-21 2023-12-28 Crispr Therapeutics Ag Methods and compositions for in vivo editing of stem cells
WO2023250511A2 (en) 2022-06-24 2023-12-28 Tune Therapeutics, Inc. Compositions, systems, and methods for reducing low-density lipoprotein through targeted gene repression
WO2024003786A1 (en) 2022-06-29 2024-01-04 Crispr Therapeutics Ag Chimeric antigen receptor targeting gpc-3 and immune cells expressing such for therapeutic uses
US20240003871A1 (en) 2022-06-29 2024-01-04 FUJIFILM Cellular Dynamics, Inc. Ipsc-derived astrocytes and methods of use thereof
WO2024015881A2 (en) 2022-07-12 2024-01-18 Tune Therapeutics, Inc. Compositions, systems, and methods for targeted transcriptional activation
WO2024013514A2 (en) 2022-07-15 2024-01-18 Pig Improvement Company Uk Limited Gene edited livestock animals having coronavirus resistance
WO2024023804A2 (en) 2022-07-29 2024-02-01 Crispr Therapeutics Ag Genetically engineered immune cells having disrupted transporter associated with antigen processing binding protein (tapbp) gene
WO2024023802A2 (en) 2022-07-29 2024-02-01 Crispr Therapeutics Ag Genetically engineered immune cells having disrupted transporter associated with antigen processing-2 (tap-2) gene
WO2024023801A2 (en) 2022-07-29 2024-02-01 Crispr Therapeutics Ag Genetically engineered immune cells having disrupted transporter associated with antigen processing-1 (tap-1) gene
US20240067968A1 (en) 2022-08-19 2024-02-29 Tune Therapeutics, Inc. Compositions, systems, and methods for regulation of hepatitis b virus through targeted gene repression
WO2024064642A2 (en) 2022-09-19 2024-03-28 Tune Therapeutics, Inc. Compositions, systems, and methods for modulating t cell function
WO2024062388A2 (en) 2022-09-20 2024-03-28 Crispr Therapeutics Ag Genetically engineered immune cells expressing chimeric antigen receptor targeting cd20

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4014808A (en) * 1973-06-04 1977-03-29 Tennant Company Detergent composition
GB8723776D0 (en) * 1987-10-09 1987-11-11 Procter & Gamble Ltd Toilet compositions
GB8811953D0 (en) * 1988-05-20 1988-06-22 Unilever Plc General-purpose cleaning compositions
JP2523837B2 (en) * 1988-11-25 1996-08-14 花王株式会社 Detergent composition for flush toilet
GB8914462D0 (en) * 1989-06-23 1989-08-09 Unilever Plc Cleaning composition
JP2952555B2 (en) * 1993-12-28 1999-09-27 花王株式会社 Hard surface cleaning composition
JP3347250B2 (en) * 1995-12-20 2002-11-20 花王株式会社 Antifouling detergent composition for toilet
JP3441885B2 (en) * 1996-06-14 2003-09-02 花王株式会社 Toilet cleaner composition
JPH10195498A (en) * 1996-12-27 1998-07-28 Lion Corp Liquid detergent composition
US5858939A (en) * 1997-03-21 1999-01-12 Lever Brothers Company, Division Of Conopco, Inc. Method for preparing bars comprising use of separate bar adjuvant compositions comprising benefit agent and deposition polymer
JP3025757B2 (en) * 1997-09-02 2000-03-27 花王株式会社 Disinfectant cleaning composition for floors
PL188065B1 (en) * 1997-09-12 2004-12-31 Izabella Bogacka Method of obtaining daily personal hygiene agents
JP2002527575A (en) * 1998-10-13 2002-08-27 ザ、プロクター、エンド、ギャンブル、カンパニー Laundry detergent composition having cationically charged dye-retaining polymer
ATE390474T1 (en) * 1999-12-08 2008-04-15 Unilever Nv USE OF POLYMERIC MATERIAL TO TREAT HARD SURFACES

Also Published As

Publication number Publication date
JP2002060786A (en) 2002-02-26
WO2002016536A1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
TWI283267B (en) Bactericidal antifouling detergent for hard surface
AU2022203717B2 (en) Use of fluorescent polymers in marking compositions for the diagnostic determination of cleaning performance
JP2003096493A (en) Germicidal antifouling detergent for rigid surface
TWI584731B (en) Antibacterial agents
MX2008002238A (en) Acidic cleaning composition containing a hydrophilizing polymer.
CN110591833B (en) Toilet cleaning agent and preparation method thereof
EP1476529A1 (en) Antifouling detergent for hard surfaces
JP3422978B2 (en) Cleaning composition for hard surfaces
MXPA05002737A (en) Cleaning composition containing a hydrophilizing polymer.
JP3617813B2 (en) Cleaning composition for hard surface
JP4008364B2 (en) Antifouling cleaner for hard surfaces
JP2002348596A (en) Cleanser composition
JP3558907B2 (en) Hard surface antifouling antibacterial detergent composition
JP3405970B2 (en) Cleaning composition for hard surfaces
PT1423495E (en) Anti-lime scale cleaning composition
JP2012092320A (en) Biofilm removing agent, composition for removing biofilm, and method for removing biofilm
JP2005008703A (en) Mildewproofing method for hard surface
JP7241479B2 (en) Coating agent for toilet bowl
JP2003238997A (en) Concentrated liquid cleaning agent for flush toilet
NZ728055B2 (en) Use of fluorescent polymers in marking compositions for the diagnostic determination of cleaning performance

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees